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Abstract
G-protein–coupled receptors (GPCRs) are generally thought to signal to second messengers like cyclic AMP (cAMP) from the
cell surface and to become internalized upon repeated or prolonged stimulation. Once internalized, they are supposed to
stop signaling to second messengers but may trigger nonclassical signals such as mitogen-activated protein kinase (MAPK)
activation. Here, we show that a GPCR continues to stimulate cAMP production in a sustained manner after internalization.
We generated transgenic mice with ubiquitous expression of a fluorescent sensor for cAMP and studied cAMP responses to
thyroid-stimulating hormone (TSH) in native, 3-D thyroid follicles isolated from these mice. TSH stimulation caused
internalization of the TSH receptors into a pre-Golgi compartment in close association with G-protein as-subunits and
adenylyl cyclase III. Receptors internalized together with TSH and produced downstream cellular responses that were
distinct from those triggered by cell surface receptors. These data suggest that classical paradigms of GPCR signaling may
need revision, as they indicate that cAMP signaling by GPCRs may occur both at the cell surface and from intracellular sites,
but with different consequences for the cell.
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Introduction
G-protein–coupled receptor (GPCR) signaling is thought to
involve a series of steps occurring at the cell surface: coupling of
receptors to G-proteins, activation of G-proteins, and ultimately,
triggering of G-protein-regulated effectors (i.e., adenylyl cyclase,
phospholipase C, calcium channels, GIRK channels, etc.) [1].
Soon after activation, many GPCRs desensitize in a process that
involves phosphorylation by G-protein–coupled receptor kinases
(GRKs) and binding of b-arrestins [1]. Subsequently, most GPCRs
are internalized via clathrin-coated pits or other less characterized
pathways, and are either dephosphorylated and recycled back to
the cell surface or targeted to lysosomes for degradation [1].
Although receptor internalization was originally considered to
contribute to desensitization by reducing the number of receptors
present on the cell plasma membrane, endocytosis has been
subsequently and unexpectedly found to promote or even be
required for receptor resensitization [1,2]. Furthermore, novel
data suggest that receptor internalization does not always lead to
signal termination. This possibility has been clearly demonstrated
for tyrosine kinase receptors, such as the epidermal growth factor
receptor (EGFR), that were shown to continue signaling after
being internalized [3–6]. In the case of GPCRs, instead,
internalized receptors are thought capable of switching to a
‘‘nonconventional’’ signaling pathway, i.e., a b-arrestin-mediated
activation of the mitogen-activated protein kinase (MAPK)
cascade [7]. A very recent study has revealed yet another type
of intracellular GPCR signaling in yeast: Gpa1, the yeast homolog
of Ga can be activated by pheromone receptors on endosomes,
where it stimulates phosphatidylinositol 3-phosphate production
[8]. Despite such recent data, there is a current consensus that
activation of canonical G-protein effectors, such as adenylyl
cyclase, by GPCRs occurs exclusively at the cell surface.
Describing the spatiotemporal dynamics of signaling cascades is
a major goal of cell biology. In the case of GPCR signaling, this
would imply answering fundamental questions such as: Where in
the cell and for how long are GPCRs active after interacting with
their ligands? Are there subcellular microdomains specialized for
different types of GPCR-mediated signals? What are the
functional consequences of GPCR internalization on signaling?
Does signaling to cyclic AMP (cAMP) or other second messengers
occur only at the plasma membrane, or are there additional sites of
GPCR activity inside the cell? Most of these questions are still
awaiting answers. The major reason for this relies on the fact that
biochemical techniques, until recently the only ones available for
such analyses, require cell disruption and therefore have limited
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limitations, we and others have developed a series of genetically
encoded fluorescent reporters that allow the direct visualization of
key steps of GPCR [9–11] and cyclic nucleotide signaling [12–19],
by means of microscopy techniques based on fluorescence
resonance energy transfer (FRET). The introduction of these
techniques has led to new insights into the mechanisms of GPCR
activation and the biology of cAMP.
Despite the important advance represented by the introduction
of FRET-based techniques, most studies required transfection of
genetically encoded fluorescent reporters into primary cells or cell
lines—thus, quite far from the physiological context. This is a
fundamental issue, as the type, location, and concentration of each
component, as well as the size and shape of cells, are expected to
greatly influence the spatiotemporal features of signaling networks
[20–22]. To be able to study GPCR-cAMP signaling in a highly
physiological context, here we generated reporter mice with
ubiquitous expression of an inert fluorescent sensor for cAMP.
These mice were utilized to study the dynamics of a GPCR-cAMP
signaling cascade, i.e., that activated by thyroid-stimulating
hormone (TSH), within the intact multicellular functional unit
that constitutes thyroid tissue.
Results
Generation of Transgenic Mice with Ubiquitous
Expression of a cAMP Sensor
To monitor cAMP levels in living cells and tissues, we generated
transgenic mice (CAG-Epac1-camps) with ubiquitous expression
of our previously described cAMP sensor (Epac1-camps) [14]. We
followed the same strategy used to create green fluorescent protein
(GFP) mice [23]. Instead of GFP, we cloned the Epac1-camps
sequence (encompassing the yellow fluorescent protein [YFP], the
cAMP binding domain of Epac1, and the cyan fluorescent protein
[CFP]) under the control of the hybrid CMV enhancer/chicken b-
actin (CAG) promoter (Figure 1A), and performed pronuclear
injections of one-cell–stage mouse embryos with this construct.
After several rounds of injections, we obtained ten PCR-positive
pups, three of which showed a high level of body fluorescence and
gave rise to transgenic offspring according to the Mendelian ratio.
Careful analysis of isolated cells and tissues from these three lines
demonstrated that two of them had a heterogeneous expression of
the sensor, which was present in only 60%–80% of the cells. By
contrast, the third line expressed Epac1-camps in virtually all cells
and was therefore chosen for subsequent experiments. Figure 1
reproduces fluorescent images of the head and a series of organs
isolated from the transgenic mice. Compared to wild-type
littermates, these mice had high levels of sensor expression in
almost all tissues and cells, excluding erythrocytes and hair. For
example, we found high fluorescence in the eye and the skin
(Figure 1B), as well as in the brain, heart, kidney, and ileum
(Figure 1C). Interestingly, transgenic mice did not show any
abnormalities and had a normal life expectancy, demonstrating
that the presence of the sensor in most cells of the organism did not
interfere with its proper development and physiological functions.
Real-Time cAMP Measurements
Next, we isolated several types of embryonic and adult primary
cells from CAG-Epac1-camps mice to measure cAMP levels in real
time. cAMP levels were monitored by FRET microscopy on live
cells as previously described [14]. From E14.5 embryos, we
obtained murine embryonic fibroblasts (MEFs) and cortical
neurons, which showed high fluorescence. Stimulation of MEFs
with the b-adrenergic agonist isoproterenol resulted in a robust
decrease ofthe YFP/CFP ratio (Figure 2A), indicative ofanincrease
of cAMP levels [14]. As already reported in other cell types [24,25],
this response was transient, due to the protein kinase A (PKA)-
dependent activation of phosphodiesterase 4 (PDE4), which could
be counteracted by addition of a specific inhibitor (rolipram). In
cortical neurons, isoproterenol induced a similar type of reaction,
though of smaller amplitude. Like in MEFs, the response was
transientandcouldbeenhancedbyadditionofrolipram(Figure2B).
From adult mice, we isolated cardiac myocytes and peritoneal
macrophages. In line with our previous observations [26], b-
adrenergic stimulation of cardiac cells led to an increase of cAMP
levels, which was further enhanced by rolipram (Figure 2C). The
cAMP response to isoproterenol in macrophages was more
sustained and only minimally affected by rolipram (Figure 2D).
Finally, the b-adrenergic antagonist propranolol completely inhib-
ited the effect of isoproterenol on cAMP production in cardiomy-
ocytes (Figure 2E) and macrophages (Figure 2F), thus showing that
the observed FRET variations were specific.
Establishment of a 3-D Culture of Thyroid Follicles
Then, we utilized CAG-Epac1-camps mice to monitor GPCR-
cAMP signaling in an intact physiological system. We chose thyroid
cellsforseveralreasons.First,thesecellsarestrictlydependentforall
their functions, e.g., thyroid hormone production and growth, on
the activation of a GPCR, the TSH receptor, which is expressed on
their basolateral membrane and the effects of which are largely
mediated by cAMP [27,28]. Second, thyroid cells form supracel-
lular structures, known as thyroid follicles, which constitute both the
anatomical and the functional units of thyroid tissue. Importantly, it
Author Summary
Cells respond to many environmental cues through the
activity of cell surface receptor proteins, which sense these
cues and convey that information to signaling molecules
inside the cell. G-protein–coupled receptors (GPCRs) form
the largest eukaryotic family of plasma membrane
receptors. They convert the information provided by
extracellular stimuli into intracellular second messengers,
like cyclic AMP (cAMP). After prolonged stimulation, they
are internalized inside cells, an event that to date has been
thought to terminate the production of second messen-
gers. Though many of the key steps of GPCR signaling are
known in detail, precisely how signaling and termination
actually occur in time and space (i.e., in subcellular
compartments or microdomains) is still largely unexplored.
To observe GPCR signaling in living cells, we generated
mice expressing a fluorescent sensor that allows monitor-
ing the intracellular levels of cAMP with a microscope. We
utilized this system to study, directly in native thyroid
follicles, the signal sent by the receptor for thyroid-
stimulating hormone (TSH). Our findings indicate that TSH
receptors are internalized rapidly after activation but
continue to stimulate cAMP production inside cells and
that this sustained, cAMP production is apparently
required for localized activation of downstream compo-
nents. These data challenge the current model of the
GPCR-cAMP pathway by suggesting the existence of
previously unrecognized intracellular site(s) for cAMP
generation and of differential signaling outcomes as a
result of intracellular GPCR signaling. Such intracellular
site(s) may provide specialized signaling platforms, thus
contributing to the spatiotemporal regulation of cAMP
production and to signaling specificity within the GPCR
family.
TSH Receptor-cAMP Intracellular Signaling
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original 3-D structure and polarization, which is reflected by a high
spatial organization of the TSH receptor-cAMP signaling cascade
[27,29,30] (Figure 3A). Thus, they represent a unique model to
study the spatiotemporal dynamics of GPCR-cAMP signaling. For
this purpose, we established a method that allowed us to isolate,
maintain, visualize, and manipulate mouse thyroid follicles under
the microscope. Among various protocols, the best results were
obtained by enzymatic dissociation followed by deposition on a thin
layer of collagen gel (Figure 3B). This protocol preserved good 3-D
morphology for at least 24–48 h of culture, without hampering
microscopic observation or manipulation (Figure 3B and Video S1).
Real-Time Monitoring of cAMP Levels in Intact Thyroid
Follicles
Next, we utilized thyroid follicles isolated from CAG-Epac1-camps
mice to monitor in real time the cAMP response to TSH stimulation.
Saturating concentrations of TSH resulted in a fast and robust
decrease of the YFP/CFP ratio (Figure 4A and 4B and Video S2),
Figure 1. Generation and characterization of CAG-Epac1-camps transgenic mice. (A) Expression cassette used to generate the transgenic
mice. The cAMP sensor (Epac1-camps) contains a cAMP binding domain derived from Epac1, flanked on either side by YFP and CFP. The Epac1-camps
sensor is under the control of the ubiquitous CAG promoter. (B) Fluorescent image of the head of a transgenic (TG) mouse compared to that of a
wild-type (WT) littermate. (C) Fluorescent images of different organs isolated from adult TG and WT mice.
doi:10.1371/journal.pbio.1000172.g001
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Epac1-camps sensor was not saturated, as shown by the further
decrease of FRETvalues obtained by fullyactivating adenylyl cyclase
with forskolin. In contrast to what was observed in other cell types,
like for example, embryonic fibroblasts and cortical neurons (for
comparison see Figure 2A and 2B), no reduction of cAMP levels was
seen after prolonged exposure to various concentrations of TSH (up
to 30 min), consistent with limited or no PDE activation under our
experimental conditions (Figure 4C). This type of sustained cAMP
response further drove our attention to TSH receptor signaling in
thyroid cells.
To rule out the possibility that the presence of the Epac1-camps
sensor might interfere with cAMP signaling, we compared the
cAMP-response to TSH stimulation in thyroid cells isolated from
wild-type and CAG-Epac1-camps mice. The intracellular levels of
cAMP, measured by an immunoenzymatic assay, were indistin-
guishable between wild-type and transgenic cells (Figure S1).
Temporal Dynamics of cAMP Signaling in Thyroid
Follicles
Importantly, the lack of appreciable desensitization of the TSH
receptor-cAMP signal allowed us to evaluate the kinetics of the return
Figure 2. Real-time monitoring of cAMP levels in different types of primary cells isolated from the cAMP reporter mice. Cells were
visualized by time-lapse fluorescence microscopy. The graphs show normalized YFP/CFP ratio values calculated from CFP and YFP images. A
reduction of the YFP/CFP ratio is indicative of an increase of cAMP levels. (A) Murine embryonic fibroblasts (MEFs) were stimulated with the b-
adrenergic agonist isoproterenol. The cAMP response to isoproterenol was robust but transient due to the activation of PDE4, as indicated by the
strong effect of the PDE4-selective inhibitor rolipram. (B) Cortical neurons reacted to isoproterenol and rolipram in a similar way. (C) The responset o
b-adrenergic stimulation of cardiac cells was further enhanced by rolipram. (D) Peritoneal macrophages showed a more sustained increase in cAMP
levels after isoproterenol stimulation and a minor effect of rolipram. (E and F) The isoproterenol effect on cardiac myocytes (E) and macrophages (F)
was completely blocked by the b-adrenergic antagonist propranolol. Traces in (A–F) are representative of three to ten experiments per condition.
doi:10.1371/journal.pbio.1000172.g002
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controlled and fast stimulation, thyroid follicles were kept under
laminar-flow perfusion with an apparatus that allowed the rapid
exchange between different extracellular solutions. First, we applied
very short (10 s) and repeated stimuli with TSH (30 U/l), which were
followed by a complete return of cAMP to basal values (Figure 5A).
Then, we stimulated thyroid follicles with saturating (30 U/l) or supra-
saturating (300 U/l) concentrations of TSH for 30 s (Figure 5B),
2 min (Figure 5C), or 10 min (Figure 5D). Note that 300 U/l were
required to reach maximum activation within 30 s, whereas 30 U/l
were sufficient for 2-min and 10-min applications. Stimulation with
these fully activating concentrations of TSH produced comparable
changes of cAMP levels, independently of the duration of the
application (Figure 5E). Unexpectedly, stimuli of duration equal or
longer than 30 s were associated with an incomplete return of cAMP
to basal levels even after extensive washout (Figure 5B–5D).
Interestingly, the extent of signal irreversibility increased with the
duration of the TSH application, but was not dependent on the
cumulative dose of TSH (for example, compare the effect of 300 U/l
for 30 s to that of 30 U/l for 2 min), occurred already after 30 s, and
was nearly maximal after 10-min stimulation (Figure 5F and 5G). In
contrast to TSH receptor activation, stimuli of comparable intensity
and duration with a forskolin analog, which directly activates adenylyl
cyclase, yielded completely reversible cAMP signals (Figure S2).
In theory, the incomplete restoration of cAMP levels observed
after prolonged TSH stimulation might have been due to an
inactivation of PDEs. To investigate this possibility, we added a
nonselective PDE inhibitor (IBMX) at the end of the washout phase.
In contrast to control follicles that were not previously stimulated
with TSH, on which IBMX had only a marginal effect, IBMX
treatment caused a robust increase in cAMP levels when applied
afterTSHstimulationfor10 minandsubsequentwashout(Figure6).
These results demonstrated that, after extensive washout from a
prolonged TSH stimulus, PDEs were still highly functional. Thus, it
is unlikely that an inactivation of PDEs was the cause of the
incomplete recovery of cAMP levels. On the contrary, the fast and
robust increase of cAMP levels after IBMX addition suggested that
the receptor-adenylyl cyclase system wasindeed continuing to signal.
TSH Receptor Internalization
The extent and kinetics of endogenous TSH receptor internal-
ization in primary thyroid cells have been difficult to evaluate due to
its very low expression levels. However, the available information
suggests that the TSH receptor is internalized and recycled back to
the plasma membrane, without being targeted to lysosomes [31,32].
To monitor the internalizationoftheendogenousTSHreceptor,we
utilized the well-established method offollowingthe endocytosisof a
fluorescent ligand [3]. For this purpose, we labeled bovine TSH
Figure 3. The thyroid follicle model. (A) Thyroid follicles constitute the anatomical and functional units of thyroid tissue. They are composed of a
monolayer of epithelial cells that defines an inner cavity where thyroid hormones are stored in the form of an iodinated protein (thyroglobulin). Upon
binding of TSH to its receptor located on the basolateral membrane, cAMP is produced with consequent activation of PKA and phosphorylation of a
series of targets, located in different cellular compartments (e.g., cytosol, nucleus, Golgi complex, apical membrane). These events lead to a fast
induction of thyroglobulin reuptake with release of free thyroid hormones into the blood stream and a slow up-regulation of thyroglobulin synthesis
and iodination. Thyroid cells are highly polarized, as the basolateral and apical membranes have completely different compositions and extremely
specialized functions. (B) Method used to culture thyroid follicles. Isolated mouse thyroid follicles were placed in a glass-bottom Petri dish, coated
with a thin layer of collagen gel. Shown are representative images of a single follicle isolated from CAG-Epac1-camps mice after 12 h of culture. Top
right, bright field image. Bottom left, maximum projection of YFP fluorescence (corresponding to the Epac1-camps sensor) calculated from individual
image slices on the z-axis, captured with a laser-scanning confocal microscope. Bottom right, single confocal image of YFP fluorescence.
doi:10.1371/journal.pbio.1000172.g003
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alterations of its biological activity (Figure S3A); in addition, TSH-
Alexa594 bound specifically to HEK293 cells transfected with TSH
receptor cDNA (Figure S3B).
Initially, to simultaneously monitor TSH and TSH receptor
internalization, we cotransfected HEK293 cells with a YFP-tagged
TSH receptor construct and b-arrestin 2, which in this context is
required for efficient TSH receptor internalization [33], and
stimulated them with TSH-Alexa594 for different periods of time.
Both ligand and receptor were found to cointernalize rapidly,
reaching a maximum after approximately 20 min (unpublished
data). Interestingly, 40 min after stimulation, the ligand and the
receptor still appeared to be present in the same intracellular
compartments, suggesting that they were not sorted apart during
this period of time (Figure 7).
Then, we utilized the fluorescent ligand to follow TSH receptor
internalization in primary thyroid cells. When we attempted to
visualize whole thyroid follicles loaded with TSH-Alexa594, we
found them to have a relatively high autofluorescence in the whole
visible spectrum. Thus, visualization of TSH-Alexa594 was largely
hampered, and possible only to a limited extent through spectral
unmixing. The resulting images, though of poor quality, were
suggestive of TSH-Alexa594 being efficiently internalized in
thyroid follicles (Figure S4). To better evaluate this phenomenon,
we analyzed the binding and internalization of TSH-Alexa594 in
single primary mouse thyroid cells, which showed much lower
autofluorescence. Interestingly, we found that TSH internalized
quickly, with TSH-Alexa594–positive vesicles being detectable
5 min after TSH stimulation and maximal internalization reached
approximately after 20 min (Figure 8). Importantly, at this point, a
major fraction of labeled TSH was found inside the cells, in
vesicles prevalently concentrated around the nucleus. To further
investigate the structure and the dynamics of TSH-containing
vesicles, we performed a series of time-lapse experiments on cells
stimulated with TSH-Alexa594 that were visualized with a total
internal reflection fluorescence (TIRF) microscope set to have a
high penetration depth. This approach allows us to visualize
cytoplasmic structures close to the plasma membrane with a high
signal/background ratio [34] and appeared particularly suited for
thyroid cells that assume a very thin shape in culture, having a
maximal thickness of approximately 1–2 mm only (unpublished
data). Interestingly, we found that TSH-Alexa594 was contained
in tubulovesicular organelles, forming a highly dynamic and
interconnected network (Figure 9 and Video S3), the structure of
which could be appreciated only partially by confocal microscopy.
Subcellular Localization of G-Proteins and Adenylyl
Cyclases
So far, our results suggested that the TSH receptor internalized
quickly without evidence of cAMP desensitization and that, after
Figure 4. Real-time monitoring of cAMP levels in thyroid follicles. Thyroid follicles isolated from CAG-Epac1-camps mice were visualized by
time-lapse fluorescence microscopy. (A) CFP, corrected YFP and YFP/CFP ratio images from a representative sequence, where a thyroid follicle was
stimulated with TSH followed by forskolin. (B) Normalized YFP/CFP ratio values obtained from the sequence in (A). (C) Effect of prolonged stimulation
with different concentrations of TSH on intracellular cAMP levels. Results in (A–C) are representative of five to ten experiments per condition.
doi:10.1371/journal.pbio.1000172.g004
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receptor-cAMP signal became irreversible. Of note, both phe-
nomena, i.e., receptor internalization and signal irreversibility, had
roughly similar kinetics. We therefore hypothesized that, over
time, a fraction of the receptors was brought to a state or a
compartment where they could no longer be freed of their ligands,
but were still able to signal. Trimeric G-proteins are frequently
found at non-plasma membrane compartments, such as endo-
somes, the endoplasmic reticulum, and the Golgi, where they are
thought to play roles in vesicle trafficking [8,35,36]. Similarly,
adenylyl cyclase activity and immunoreactivity have been found
on intracellular membranes, though such studies were frequently
limited by the very low expression of adenylyl cyclases and the
relatively low affinity of the available antibodies [37,38].
Therefore, it appeared possible that the other components
required for TSH receptor signaling might also be present inside
the cell. Based on these considerations, we attempted to localize
Gas as well as adenylyl cyclase III, V, and VI, the major isoforms
expressed in thyroid cells [39], by immunofluorescence. Our
results indicated that Gas was present on intracellular vesicles and
tubulovesicular structures that were typically concentrated around
the nucleus (Figures S5, 10, and 11A and 11B). Adenylyl cyclase
staining was of much lower intensity. Nonetheless, adenylyl cyclase
immunoreactivity was found occasionally on the plasma mem-
brane and largely on intracellular vesicles (Figures S5 and 11C).
TSH stimulation did not cause apparent modifications of Gas or
Figure 5. Effect of transient TSH stimulation on cAMP levels. Thyroid follicles isolated from CAG-Epac1-camps mice were visualized by time-
lapse fluorescence microscopy. (A) Effect of repeated short stimuli (10 s each) with TSH. (B–D) Effect of longer TSH applications. Reported are data
from representative experiments in which thyroid follicles were stimulated for 30 s (B), 2 min (C), or 10 min (D). (E) Mean FRET changes induced by
stimuli as in (B–D). Values were compared by one-way ANOVA. (F) Comparison of signal recovery after stimuli as in (B–D). Signal reversibility was
calculated from the YFP/CFP ratio data of the washout phase, by setting the value at the end of TSH stimulation equal to zero and the value before
TSH stimulation equal to 100%. The values obtained from different replicates were globally fitted to a first-order exponential function. Fits were
compared with F test, having a null hypothesis that Ymax values were the same for all datasets. (G) Comparison of Ymax values obtained from fitting
each dataset in (F) to a first-order exponential equation. Values were compared by one-way ANOVA, followed by Bonferroni post hoc test. Data in (E–
G) were obtained from six to eight independent experiments per condition.
doi:10.1371/journal.pbio.1000172.g005
Figure 6. Role of PDEs on cAMP signal irreversibility. (A) Thyroid
follicles isolated from CAG-Epac1-camps mice were stimulated with TSH
for 10 min followed by extensive washout. Thereafter, a nonselective
PDE inhibitor (IBMX) was added to probe the PDE activity. (B) For
comparison, the effect of IBMX was evaluated on thyroid follicles that
were not previously stimulated with TSH. Shown are representative
traces from four to six experiments per condition.
doi:10.1371/journal.pbio.1000172.g006
TSH Receptor-cAMP Intracellular Signaling
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specificity of Gas, adenylyl cyclase III, and adenylyl cyclase V/VI
staining was checked by competition with the peptides used to
raise the primary antibodies (Figure S6). In addition, the specificity
of Gas immunofluorescence was evaluated by comparing its
subcellular pattern to the localization of YFP-tagged Gas
transfected in HEK293 cells (unpublished data).
To identify the structures that were positive for Gas,w e
performed a series of colocalization experiments with markers of
intracellular compartments. First, we used a fluorescent transferrin
conjugate to label early endosomes and the recycling endosomal
compartment. This is a frequently used method that takes
advantage of the endocytosis and recycling of transferrin together
with its receptor [40]. To this end, primary mouse thyroid cells
were stimulated with fluorescent transferrin for various periods of
time (2–60 min), followed by fixation and immunofluorescent
staining of Gas. Early time points (2–5 min) were used to visualize
early endosomes, whereas later time points were employed to
identify recycling endosomes. Gas and transferrin were not found
simultaneously on early endosomes (unpublished data). However,
at later time points (20–60 min) transferrin appeared to be
contained in vesicles, presumably a recycling compartment,
associated with the perinuclear tubulovesicular structure positive
for Gas (Figure 10A). Of note, some of these vesicles were also
positive for Gas. In addition, primary mouse thyroid cells were
simultaneously treated with fluorescent transferrin and TSH to
evaluate whether they followed similar or distinct endocytic
pathways (Figure 10B and unpublished data). A partial colocaliza-
tion between internalized TSH and transferrin was observed at all
time points considered (2–60 min)—notice that in Figure 10B,
several TSH-positive vesicles contain also transferrin—suggesting
that they followed to some extent the same trafficking pathway. An
antibody against Rab7 was used to label late endosomes. No
colocalization was observed between Gas and Rab7 (Figure 10C).
Finally, an antibody against a Golgi-resident protein, Golgi 58K,
was used to mark the Golgi compartment [41]. A high degree of
colocalization was present between Gas and Golgi 58K
(Figure 10D), suggesting that a relevant fraction of Gas was
located on membranes of the Golgi complex.
Next, we treated primary thyroid cells with TSH-Alexa594, as a
marker of TSH receptor, and looked at its colocalization with Gas
and adenylyl cyclases. Interestingly, internalized TSH and Gas
were frequently found in close association, with TSH being
present on vesicles adjacent to the Gas-positive tubulovesicular
structure (Figure 11A and 11B and Video S4). As observed in the
case of transferrin, some of these vesicles were also positive for
Gas. TSH and adenylyl cyclase III were found to colocalize
occasionally on the plasma membrane and more frequently on
intracellular vesicles or tubulovesicular structures (Figure 11C and
Video S5). Little colocalization was observed between internalized
TSH and adenylyl cyclase V/VI (unpublished data).
To further investigate the subcellular localization of adenylyl
cyclases, we labeled them with BODIPY-forskolin, a fluorescent
forskolin analog [42]. The specificity of BODIPY-forskolin
staining was initially evaluated in HEK293 cells transfected with
adenylyl cyclase VI cDNA, which showed a stronger labeling
compared to control mock-transfected cells (Figure 12A). Then, we
utilized BODIPY-forskolin to stain primary thyroid cells that were
visualized with a TIRF microscope as described above. BODIPY-
forskolin staining was largely present on intracellular vesicles and
tubulovesicular structures (Figure 12B). Utilizing this approach, we
could also visualize simultaneously the internalized TSH-Alexa594
and BODIPY-forskolin in cells that were stimulated with the
fluorescent ligand. A consistent colocalization was observed at the
level of several intracellular vesicles and tubulovesicular structures,
in agreement with the previous immunofluorescence data
(Figure 12C). The dynamic nature of these intracellular structures
can be appreciated in Video S6. Finally, we utilized the fluorescent
forskolin analog to perform triple stainings in which we attempted
to simultaneously visualize the internalized TSH-Alexa594, Gas
Figure 7. Cointernalization of TSH and its receptor in HEK293 cells. HEK293 cells transfected with YFP-tagged TSH receptor and b-arrestin 2
were stimulated with 3 mg/ml TSH-Alexa594 for 40 min, fixed, and then visualized by confocal microscopy. ‘‘Basal’’ refers to control cells that were not
stimulated with TSH-Alexa594. Images are representative of three independent experiments.
doi:10.1371/journal.pbio.1000172.g007
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images were indicative of the three components being simulta-
neously present on vesicles that were often adjacent to the
perinuclear tubulovesicular structure positive for Gas (Figure 12D).
Of note, the latter structure was also labeled by BODIPY-forskolin
(Figure 12D).
Finally, we utilized immunogold electron microscopy to
evaluate the subcellular localization of the internalized TSH,
Gas, and adenylyl cyclase III at the ultrastructural level. None of
the available antibodies against Gas worked in immunogold
stainings. To visualize the internalized TSH, we labeled it with
Alexafluor488, which was recognized by a specific antibody.
Similarly to TSH-Alexa594, TSH-Alexa488 had a conserved
biological activity (unpublished data). Consistent with the previous
immunofluorescence results, both TSH-Alexa488 and adenylyl
cyclase III were found to be present in endosomes (Figure S7).
Effect of Receptor Internalization on cAMP Signaling
Although our data were so far compatible with TSH receptor
signaling from intracellular sites, direct functional evidence was
still missing. We therefore reasoned that if our hypothesis was
correct, treatments capable of inhibiting TSH receptor endocytosis
should hamper TSH receptor sequestration and, as a result,
increase the reversibility of cAMP signals after TSH washout. We
first tried several treatments that have been reported to inhibit
GPCR internalization, such as concanavalin A, phenylarsine oxide
and hypertonic sucrose [7]. Concanavalin A and phenylarsine
oxide were found to partially inhibit forskolin-dependent cAMP
production and, therefore, were not further evaluated (unpub-
lished data). By contrast, pretreatment with 0.43 M sucrose for
10 min did not hamper TSH-dependent cAMP accumulation
(Figure 13A), whereas it almost completely inhibited TSH-
Alexa594 internalization (Figure 13B, Video S7 and Video S8).
Importantly, pretreatment of thyroid follicles with hypertonic
sucrose was associated with a complete reversibility of the cAMP
signal produced by TSH stimulation for 2 min (Figure 13C). The
mechanism of action of hypertonic sucrose is not completely
understood, though this treatment is known to alter the
polymerization of clathrin, thus hampering the formation of
coated pits at a very initial phase [7]. Another frequently used
Figure 8. Time-course analysis of TSH receptor internalization. Primary thyroid cells obtained from CAG-Epac1-camps mice were stimulated
with 3 mg/ml TSH-Alexa594 for the indicated period of time, fixed, and then visualized by confocal microscopy. YFP images of Epac1-camps were
used as a cytosolic counterstain. Images are representative of 25–30 cells per condition analyzed in four independent experiments.
doi:10.1371/journal.pbio.1000172.g008
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dynamin function. Dynamin is in fact required for later phases of
clathrin-dependent endocytosis, such as pinching and release of
completed coated pits from the plasma membrane. Recently,
Macia et al. developed a membrane permeable dynamin inhibitor,
dynasore [43], which could be applied directly to intact thyroid
follicles. We therefore repeated the same experiments in the
presence of dynasore, which had a consistent inhibitory effect on
TSH internalization (Figure 13D and Video S9). Analogously to
what was observed with hypertonic sucrose, pretreatment for
20 min with 80 mM dynasore, a concentration that produced a
maximal effect on TSH internalization, resulted in a major
increase of cAMP signal reversibility after TSH washout
(Figure 13E). Taken together, these results strongly suggested that
TSH receptor internalization was responsible for the observed
irreversibility of cAMP signaling.
Effect of pH on TSH Receptor-cAMP Signaling
A possible concern when considering the occurrence of TSH
receptor signaling on endocytic membranes is the effect of acidic
pH on TSH–TSH receptor interactions. In fact, the low pH of
early (pH 5.9–6.2) and late endosomes (pH.5.0–6.0) [44] is known
to promote the dissociation of several receptor–ligand complexes.
To evaluate the effect of acidic pH on TSH receptor signaling, we
incubated primary thyroid follicles at different pH levels and
evaluated the cAMP response to TSH stimulation by FRET
microscopy. In agreement with previous observations [45], our
results suggested that efficient TSH binding and activation of the
TSH receptor was still possible at pH 5.0 (Figure S8).
Cell Fractionation Experiments
To further verify the hypothesis that the TSH receptor may
continue to signal to Gas/adenylyl cyclase after internalization, we
conducted a series of experiments based on cell fractionation.
Since in initial tests we found that these studies required a higher
amount of starting material than could be obtained from primary
thyroid cells, these experiments were performed on the FRTL5
thyroid cell line. FRTL5 cells are a widely used model of well-
differentiated thyroid cells, which, among other features of normal
thyrocytes, express thyroid-specific genes, conserve a functional
TSH receptor-cAMP signaling pathway and retain the capability
to synthesize thyroid hormones [28,46].
First, we established a method to separate the intracellular
content from the plasma membrane. In order to allow a better
characterization of the supposed intracellular TSH receptor
signaling compartment, we looked for a method that was fast, as
gentle as possible, and produced with high yield an intracellular
fraction with the lowest possible contamination from the plasma
membrane. The best results were obtained utilizing a protocol
based on the separation of the plasma membrane with magnetic
beads coated with concanavalin A, which binds selectively to the
glycoproteins present on the cell surface [47]. Figure 14A shows
the results of a typical fractionation experiment. Please notice the
virtual absence of the Na
+/K
+ ATPase, used as a plasma
membrane marker, in the intracellular fraction after the second
round of purification (lane 5).
Next, we evaluated by Western blot analysis the presence of Gas
and adenlyl cyclase III in the different subcellular fractions
(Figure 14B). As expected, bands corresponding to Gas and
adenylyl cyclase III were present in the total homogenate as well as
in the plasma membrane fraction. In addition, the same bands
were also present in the intracellular fraction, thus confirming the
evidence based on the results of the immunofluorescence
Figure 9. Dynamic visualization of internalized TSH-Alexa594.
Primary mouse thyroid cells were stimulated with 3 mg/ml TSH-
Alexa594 for 20 min. Thereafter, the TSH-Alexa594 fluorescence was
visualized with a TIRF microscope set to have a high penetration depth.
Shown are three representative frames, acquired at the indicated time
points. The arrowhead indicates a tubule that extended during the
observation. The merged image was produced by overlaying the
images of the three individual frames, after coloring them in red (0 s),
green (+38 s) and blue (+49 s). White indicates regions of the image
that did not change during this period of time. Data are representative
of 20 sequences from four independent experiments.
doi:10.1371/journal.pbio.1000172.g009
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PLoS Biology | www.plosbiology.org 10 August 2009 | Volume 7 | Issue 8 | e1000172Figure 10. Colocalization between Gas and subcellular markers. (A) Colocalization between Gas and Alexafluor488-conjugated transferrin
(transferrin-Alexa488), used to visualize early and recycling endosomes. Primary mouse thyroid cells were stimulated for various periods of time (2–
60 min) with transferrin-Alexa488, followed by immunofluorescence analysis for Gas. No colocalization was observed at early time points (2–5 min)
(unpublished data). At later time points (20–60 min), transferrin appeared to be contained in vesicles associated with the perinuclear tubulovesicular
structure positive for Gas. Some of these vesicles were also positive for Gas. Reported is a representative image of a cell treated with transferrin-
Alexa488 for 20 min. (B) Colocalization between TSH-Alexa594 and transferrin-Alexa488, in a cell that was simultaneously treated with both
fluorescent ligands for 20 min. A partial colocalization between TSH-Alexa594 and transferrin-Alexa488 was observed. (C) Colocalization between Gas
and Rab7, used as a marker of late endosomes. Cells were analyzed by double-immunofluorescence with antibodies against Gas and Rab7. No
colocalization was observed. (D) Colocalization between Gas and Golgi 58K, used as a marker for the Golgi complex. Cells were analyzed by double-
immunofluorescence with antibodies against Gas and Golgi 58K. A high degree of colocalization was observed. Images in (A–D) are representative of
more than 20 cells per condition analyzed in at least three independent experiments.
doi:10.1371/journal.pbio.1000172.g010
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PLoS Biology | www.plosbiology.org 11 August 2009 | Volume 7 | Issue 8 | e1000172Figure 11. Subcellular localization of Gas, adenylyl cyclase III, and internalized TSH in primary thyroid cells. Primary mouse thyroid
cells were stimulated with 3 mg/ml TSH-Alexa594 for 10 min, followed by immunofluorescence analysis with antibodies against Gas (A and B) or
adenylyl cyclase III (C). Image stacks on the z-axis were acquired with a laser-scanning confocal microscope. Shown are representative frames. The
‘‘3D’’ in the panels refer to 3-D reconstructions of the areas indicated by the white boxes, calculated from the z-stacks. Here, the reconstructions are
observed from the top. To view a complete rotation on the x-axis of the 3D reconstructions, see Videos S4 and S5. (B) Side-view of the z-stack in (A),
cut along the white line, showing a Gas-positive tubule ending in a vesicle positive for both Gas and TSH-Alexa594. Throughout the figure, yellow in
the merged images is indicative of colocalization. Images in (A–C) are representative of 25–30 cells per condition analyzed in at least three
independent experiments.
doi:10.1371/journal.pbio.1000172.g011
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significant amounts also in the intracellular compartment.
Once the fractionation method was established, we attempted to
directly measure the activity of adenylyl cyclase in the plasma
membrane and in the intracellular fraction of cells that were
previously stimulated with TSH. The prediction was that if the
TSH receptor continued to signal to Gas/adenylyl cyclase after
internalization, this should result in an increase of the adenylyl
cyclase activity in the intracellular fraction. This appeared to be
indeed the case, as we found that pretreatment of FRTL5 cells for
30 min with TSH was associated with an increased adenylyl
cyclase activity in the intracellular fraction (Figure 14C). By
Figure 12. BODIPY-forskolin labeling of adenylyl cyclases. (A) Test experiment in HEK293 cells. HEK293 cells were either transfected with
canine adenylyl cyclase VI cDNA (AC VI) or mock transfected (M.T.). Forty-eight hours after the transfection, they were stained with BODIPY-forskolin
and directly visualized with a fluorescent microscope. Note the higher staining in cells overexpressing adenylyl cyclase VI. (B) BODIPY-forskolin
labeling of primary thyroid cells. Mouse primary thyroid cells were stained with BODIPY-forskolin and visualized with a TIRF microscope set to have a
high penetration depth. (C) Live-cell imaging of adenylyl cyclases and internalized TSH in primary thyroid cells. Primary mouse thyroid cells were
stimulated with 3 mg/ml TSH-Alexa594 for 20 min, followed by 10 min staining with BODIPY-forskolin. TSH-Alexa594 and BODIPY-forskolin were
visualized with a TIRF microscope as above. A frequent colocalization between TSH-Alexa594 and BODIPY-forskolin on intracellular vesicles and small
tubulovesicular structures was observed. (D) Triple staining for adenylyl cyclases, Gas, and TSH. Mouse primary thyroid cells were stimulated with
3 mg/ml TSH-Alexa594 for 20 min, fixed, and then processed for Gas immunofluorescence. Immediately before imaging, the coverslips were mounted
in an experimental chamber, stained with BODIPY-forskolin, and directly visualized with a confocal microscope. White is indicative of triple
colocalization. Images in (A) are representative of three independent experiments. Images in (B–D) are representative of more than 20 cells per
condition analyzed in at least three independent experiments.
doi:10.1371/journal.pbio.1000172.g012
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modifications of the adenylyl cyclase activity in the plasma
membrane fraction. This is not surprising, as TSH is expected to
dissociate from the TSH receptors present on the plasma
membrane during the time required for the cell fractionation.
Nevertheless, a certain amount of functional receptors was left on
the plasma membrane, as adenylyl cyclase activity in this fraction
could be increased by adding TSH in the reaction mixture
(Figure 14C).
Altogether, these results further supported the hypothesis that
the TSH receptor continued to signal to Gas/adenylyl cyclase
after internalization.
Simulations
To better understand the possible consequences of intracellular
GPCR signaling, we generated a mathematical model of the
GPCR-cAMP pathway. Our model is based on the recent work
done by Neves et al. on b2-adrenergic receptor signaling [21]. In
this model, the receptor, G-proteins and adenylyl cyclase are
placed on the plasma membrane, whereas ATP, cAMP, PDE4,
and PKA are cytosolic (Figure 15A). In addition, to mimic an
intracellular signaling compartment (ICSC), we placed G-proteins
and adenylyl cyclase also on an intracellular membrane and
simulated the internalization of both GPCR and ligand to this
compartment (Figure 15B). Simulations were performed with the
Virtual Cell software [48–50]. Initial non-spatially resolved
simulations, aimed at validating the model and assessing the
effects of different geometries and parameters as well as of receptor
recycling, are described in Text S1 and Figures S9, S10, S11.
Subsequently, a system of partial differential equations was used to
obtain a spatiotemporal description of the GPCR-cAMP pathway.
The results of the simulations performed with this model were in
good agreement with our experimental data. In Figure 15C are
reported the results of a spatial simulation in which a cell was given
a transient stimulus, by mimicking a perfusion system that
provided and subsequently removed the ligand from the
extracellular space. Notice that in the absence of the ICSC, the
cAMP response is fully reversible. On the contrary, in the presence
of the ICSC, the signal is no longer reversible, in agreement with
the results of the FRET experiments. Interestingly, the different
types of cAMP gradients generated in the presence or absence of
the ICSC are also reflected by different degrees and spatial
patterns of PKA activation. Thus, our mathematical model
predicted that GPCR signaling to cAMP from an ICSC should
have important consequences also on the spatiotemporal dynamics
of downstream signaling events.
Functional Consequences of cAMP Signaling from
Internalized Receptors
Based on the results of the mathematical simulations, we
investigated whether the inhibition of TSH receptor internaliza-
tion had some effects on the signaling events downstream of cAMP
Figure 13. Effect of endocytosis inhibition on cAMP signaling. Cells were prestimulated with 0.43 M sucrose for 10 min, 80 mM dynasore for
20 min, or normal medium as control. (A) Comparison of FRET changes induced by stimulating thyroid follicles obtained from CAG-Epac1-camps mice
with TSH (30 U/l for 2 min, as in Figure 5C) in the presence or absence (control) of endocytosis inhibitors (n=6–8 per each condition). Error bars
indicate SEM. (B) Confocal image of a primary mouse thyroid cell stimulated with TSH-Alexa594 (3 mg/ml for 20 min) in the presence of 0.43 M
sucrose. Note the binding of TSH-Alexa594 to the plasma membrane (arrowheads) and the almost complete inhibition of TSH-Alexa594
internalization (no intracellular vesicles). For comparison, see Figure 8 (20 min). (C) Comparison of cAMP signal reversibility after TSH stimulation
(30 U/l for 2 min) in the presence or absence (control) of 0.43 M sucrose (n=6, each). (D) Confocal image of a primary mouse thyroid cell stimulated
with TSH-Alexa594 (3 mg/ml for 20 min) in the presence of 80 mM dynasore, showing consistent inhibition of TSH-Alexa594 internalization.
Arrowheads, TSH-Alexa594 bound to the plasma membrane. (E) Comparison of cAMP signal reversibility after TSH stimulation (30 U/l for 2 min) in the
presence or absence (control) of 80 mM dynasore (n=6, control; n=8, dynasore). Signal reversibility in (C) and (E) is calculated as in Figure 5F. Fits
were compared with F test, having a null hypothesis that Ymax values were the same for all datasets. Images in (B) and (D) are representative of more
than 20 cells per condition analyzed in three independent experiments.
doi:10.1371/journal.pbio.1000172.g013
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reorganization of the actin cytoskeleton. This is a well-known
phenomenon, mainly consisting in the depolymerization of stress
fibers, that is implicated in the reuptake of thyroglobulin and in the
induction of thyroid-specific genes [51–53]. Therefore, we
evaluated whether blocking receptor internalization might affect
the depolymerization of actin in response to TSH (Figure 16A and
16B). Primary mouse thyroid cells were stimulated with TSH in
the presence or absence of endocytosis inhibitors, as described
above, then fixed and stained for actin with fluorescent phalloidin.
Hypertonic sucrose itself was found to induce a modification of
actin architecture, and was not further evaluated (unpublished
data). Instead, dynasore treatment did not cause any appreciable
modifications of cellular shape or actin polymerization
(Figure 16A). As expected, TSH alone caused a generalized
depolymerization of actin, which was observed both in the central
cellular compartment (Figure 16A) and in lamellipodia
(Figure 16B). By contrast, in the presence of dynasore, TSH
induced only a partial depolymerization in the central cellular
compartment (Figure 16A) and failed to induce depolymerization
in lamellipodia, which showed an even thicker actin mesh
compared to that of control cells (Figure 16B).
The PKA-substrate vasodilator-stimulated phosphoprotein
(VASP) is a key effector of cAMP in the reorganization of actin
cytoskeleton [54,55]. VASP is concentrated at actin hot spots
(lamellipodia, filopodia, cell–substrate, and cell–cell contacts) where
it regulates the polymerization and branching of actin filaments.
Importantly,itsfunction is regulatedby PKAvia phosphorylationat
Ser 157 [54,55]. We therefore investigated whether VASP was
phosphorylated in response to TSH stimulation in thyroid cells and
the possible consequences of TSH receptor internalization on this
pathway. VASP phosphorylation was evaluated by Western blot
analysis, both by monitoring the intensity of the slower migrating
band detected by a VASP antibody and by utilizing an antibody
specific for VASP phosphorylated at Ser 157. In the absence of
endocytosis inhibitors, TSH caused a 2-fold induction of VASP
phosphorylation. However, pretreatment with endocytosis inhibi-
tors caused a substantial reduction of VASP phosphorylation in
response to TSH (Figures 16C and S12).
To confirm the possible involvement of VASP in the control of
actin polymerization in thyroid cells, we examined its subcellular
localization by immunofluorescence. As observed in other cells in
which VASP regulates actin polymerization, VASP was concen-
trated at the ends of actin filaments (Figure 16D).
Finally, we evaluated whether blocking TSH receptor internal-
ization also altered the spatial pattern of VASP phosphorylation by
PKA. To this end, we stimulated thyroid cells with TSH alone or
in the presence of dynasore, and visualized VASP phosphorylated
at Ser 157 by immunofluorescence (Figure 16E). In the absence of
dynasore, TSH caused a robust increase of VASP phosphorylation
throughout the cell. In particular, phosphorylated VASP coloca-
lized with spots of depolymerized actin in the central cellular
compartment. By contrast, only a minor induction of VASP
phosphorylation and no spots of phosphorylated VASP in the
central cellular compartment were observed in the presence of
dynasore (Figure 16E). As a control, the generalized depolymer-
ization of actin and the pattern of VASP phosphorylation induced
by forskolin were not modified by dynasore (Figure 16F).
Taken together, these results suggest that TSH receptor
internalization not only modifies the temporal dynamics of cAMP
signaling by leading to persistent cAMP production, but may also
affect the intensity and the spatial patterning of downstream signals.
Discussion
The conventional model of GPCR signaling is based on the
central concept that signaling to second messengers such as cAMP
is taking place only at the cell plasma membrane [1]. The role
assigned to receptor internalization is essentially to reduce the
number of GPCRs present on the cell surface, thus contributing to
signal desensitization, or to bring the receptors to an intracellular
site for dephosphorylation and resensitization [1,2,56]. Whatever
the fate of the internalized GPCRs, they are thought to stop
Figure 14. Cell fractionation experiments. The plasma membrane
and the intracellular fractions of FRTL5 cells were obtained by
separation with concanavalin A-coated magnetic beads. (A) Western
blot analysis of subcellular markers in the obtained fractions. The
following markers were used: Na
+/K
+ATPase for the plasma membrane,
the early endosome antigen 1 (EEA1) for early endosomes, and Golgi
58K for the Golgi complex. 1, total homogenate. 2, first eluate from the
magnetic beads, corresponding to the plasma membrane fraction. 3,
postnuclear supernatant. 4, second eluate from the magnetic beads. 5,
intracellular fraction. (B) Western blot for Gas and adenylyl cyclase III (AC
III) in the same fractions as in (A). (C) Effect of TSH stimulation on
adenylyl cyclase activity in the subcellular fractions. FRTL5 cells were
starved for 24 h in medium without TSH and either stimulated with
30 U/l TSH for 30 min or mock stimulated (control), followed by cell
fractionation with concanavalin A-coated magnetic beads. The adenylyl
cyclase activity in the plasma membrane and intracellular fractions was
then determined in the absence of stimuli (2) or in the presence of
either 30 U/l TSH (+TSH) or 10 mM forskolin. The results were
normalized for the maximal adenylyl cyclase activity measured in the
presence of forskolin. Shown are the data from three independent
experiments. Error bars indicate SEM.
doi:10.1371/journal.pbio.1000172.g014
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PLoS Biology | www.plosbiology.org 15 August 2009 | Volume 7 | Issue 8 | e1000172Figure 15. Mathematical model of the GPCR-cAMP signaling pathway. A model of spatial partial differential equations was generated to
simulate the temporal and spatial dynamics of GPCR signaling. (A) Schematic illustration of the basic model. The receptor, G-proteins, and adenylyl
cyclase are placed on the plasma membrane, whereas ATP, cAMP, and PDE4 are freely diffusing in the cytosol. PKA is cytosolic, but nondiffusing. (B)
Model with the addition of an intracellular signaling compartment (ICSC). To simulate GPCR-cAMP signaling from an ICSC, we placed G-proteins and
adenylyl cyclase also on an intracellular membrane and simulated the internalization of both GPCR and ligand to this compartment. (C) Results of
simulations. A cell was transiently stimulated by application and removal of the ligand from the extracellular compartment. In a first simulation in
which signaling from the ICSC was not implemented (no ICSC), the cAMP response was completely reversible. On the contrary, inclusion of the ICSC
in the model lead to sustained cAMP production. Also note the different levels and spatial patterns of PKA activation predicted in the presence or
absence of the ICSC.
doi:10.1371/journal.pbio.1000172.g015
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provide evidence that a GPCR continues to stimulate cAMP
production after internalization. cAMP signaling by internalized
receptors appears to be different from that occurring at the plasma
membrane, as it is of a sustained nature and leads to a different
pattern of downstream signals.
Although the biochemical steps involved in GPCR signaling are
known in detail, their location in space and time in living cells is
Figure 16. Effect of endocytosis inhibition on downstream signaling. (A and B) Actin depolymerization in response to TSH. Mouse primary
thyroid cells were preincubated with normal medium or medium plus 80 mM dynasore for 20 min and stimulated with 30 U/l TSH for an additional
20 min in the presence or absence of dynasore as indicated. Cells were then fixed, and actin was stained with fluorescent phalloidin. Note that
dynasore largely prevented the depolymerization of actin in response to TSH. (B) High-magnification images of actin rearrangement in lamellipodia,
where the effect of dynasore was more pronounced. (C) VASP phosphorylation. Primary mouse thyroid cells were preincubated with normal medium
or medium plus 80 mM dynasore for 20 min. Cells were then stimulated with 1 U/l TSH for 30 min, in the presence or absence of dynasore as
indicated. Levels of P-VASP (Ser 157) and total VASP were evaluated by Western blot analysis. Shown are the mean P-VASP levels of three
independent experiments. Error bars indicate SEM. (D) Subcellular localization of VASP. Mouse primary thyroid cells were labeled by
immunofluorescence with an antibody against total VASP (red) together with fluorescent phalloidin to stain actin (green). Shown is a merged
fluorescent image. VASP is typically located at the ends of actin filaments. (E) Pattern of VASP phosphorylation in response to TSH. Mouse primary
thyroid cells were preincubated and stimulated with TSH in the presence or absence of dynasore as explained above. Cells were then labeled by
immunofluorescence with an antibody against VASP phosphorylated at Ser 157 (red) together with fluorescent phalloidin to stain actin (green). Note
the appearance of spots containing phosphorylated VASP and actin in the central cellular compartment only in the absence of dynasore. (F) Actin
depolymerization and pattern of VASP phosphorylation in response to forskolin. Cells were treated as in (E), with the exception that instead of TSH,
they were stimulated with 10 mM forskolin. Note a similar degree of actin depolymerization and a similar pattern of VASP phosphorylation both in the
presence and in the absence of dynasore. Images in (A and B) and (D–F) are representative of at least three independent experiments.
doi:10.1371/journal.pbio.1000172.g016
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emerging evidence that signaling cascades are highly organized in
space and time, and intrinsically dynamic [20]. On such a basis,
there is an urgent need to develop new tools and techniques to
monitor signaling events with submicrometer resolution and fast
temporal dynamics. Recently, the application of FRET to color
variants of Aequorea victoria GFP has allowed the development of a
toolbox of genetically encoded sensors to observe intracellular
signaling events in real time. Several sensors have been described
that exhibit FRET changes on exposure to cAMP [57]. A sensor
based on the dissociation of the PKA subunits was first described
by Adams et al. (using rhodamine and fluorescein as fluorophores)
[58] and later modified by Zaccolo and colleagues to be genetically
encoded by substituting rhodamine and fluorescein with GFP
variants [12,13]. This sensor has led to major insights into the
biology of cAMP [13,25,59–61]. We have recently described
another type of sensors, including Epac1-camps, that are based on
a single cAMP-binding domain derived from cAMP-binding
proteins [14,26]. These sensors, being based on a cAMP-binding
domain alone and not on the entire protein, are devoid of any
signaling activity. Therefore, they are extremely well tolerated and
are expected not to alter the functions of the cell [57]. This is
probably why the CAG-Epac1-camps mice are viable and healthy,
whereas attempts to create genetically modified organisms with
ubiquitous expression of PKA-based sensors have so far been
unsuccessful [62,63].
The newly generated cAMP reporter mice were used to monitor
GPCR signaling in living cells. A major strength of our study was
the use of a highly physiological system, i.e., 3-D thyroid follicles.
Thyroid follicles represent a unique model to study the
spatiotemporal dynamics of cAMP signaling because they
maintain the supracellular organization, size, and polarization
possessed by thyroid cells in vivo, and constitute a rare example of
cells that are under the strict control of a GPCR (the TSH
receptor) and of cAMP for virtually all their functions (e.g., thyroid
hormone production, cell proliferation) [27,28]. The conservation
of the original cellular architecture of thyroid tissue is reflected by
the high degree of spatial organization of the TSH receptor-cAMP
signaling cascade: the TSH receptor is expressed on the
basolateral membrane; upon binding of TSH, cAMP produced
at the basolateral membrane diffuses through the cytosol to
activate cytosolic PKA I and PKA II, mainly located in the Golgi
complex; PKAs in turn phosphorylate targets localized in different
cellular compartments (e.g., cytosol, nucleus, as well as apical and
basolateral membranes) [27,28,64–66]. The maintenance of the
original cellular size and shape is of fundamental importance, as
modifications of these parameters are expected to alter the
properties of signaling cascades, including the shape of the
gradients of cAMP and other soluble messengers [20–22]. Another
advantage of thyroid follicles is that they already express all the
required signaling machinery at endogenous levels. Here, we
describe a method to directly visualize cAMP signaling in thyroid
follicles, thus allowing, for the first time to our knowledge, a
precise monitoring of the kinetics of a GPCR-cAMP signaling
cascade, at endogenous levels of expression and in its native
multicellular functional unit. We believe that this represents a
major step towards depicting signaling pathways in their natural
context.
By monitoring cAMP signaling and receptor internalization, we
obtained a series of unexpected findings. First, the TSH receptor
internalizes rapidly and consistently into a pre-Golgi compartment
in close association with Gas and adenylyl cyclase III. Second, the
robust internalization of the TSH receptor is not associated with
any appreciable desensitization of the cAMP signal. Third,
prolonged TSH receptor stimulation leads to a sustained
production of cAMP; by contrast, short stimuli are completely
reversible. Fourth, blocking receptor internalization can prevent
the irreversibility of cAMP signals. Fifth, TSH receptor internal-
ization is required to ensure a normal pattern of actin
rearrangement and VASP phosphorylation downstream of cAMP.
On the basis of these findings, we suggest that the TSH receptor
continues to signal to adenylyl cyclase after internalization, and
that the location of TSH receptor-cAMP signaling affects the
spatial patterns of the downstream signals.
The consequences of GPCR signaling from inside the cell
appear to be multiple, as anticipated by Miaczynska et al. [4].
First, sustained cAMP production from internalized receptors may
provide a memory mechanism, allowing thyroid cells to maintain
constant thyroid hormone production in the presence of
fluctuations in plasma TSH concentration. Indeed, TSH release
from the pituitary follows a circadian rhythm, with a zenith in the
first hours of the morning, but those fluctuations are not associated
with a change in the production of thyroid hormones [67].
Additionally, intracellular membranes may provide specialized
platforms for signal compartmentalization. This is the case of
MAPK activation by GPCRs, which appears to happen selectively
on endosomes [7], and of tyrosine kinase receptors that activate a
distinct subset of substrates once inside the cell [3–6]. In the case of
cAMP signaling, internalized receptors appear to be more
efficiently coupled to PKA, as suggested by the effect of
endocytosis inhibitors on VASP phosphorylation. This could be
explained if the receptors need to be brought close to an
intracellular pool of PKA for efficient kinase activation and/or
VASP phosphorylation.
The existence of spatial microdomains of cAMP signaling inside
the cell has been debated for years. Unlike Ca
++, whose apparent
diffusion is limited by the high buffering capacity of cytosolic
proteins [68,69], measurement of cAMP diffusion gave values in
the range of 270–780 mm
2/s, i.e., as fast as would be expected in a
simple electrolyte solution [70,71]. For this reason, cAMP has
been traditionally considered a far-reaching messenger, capable of
crossing the whole cell to convey the information generated at the
plasma membrane. Although this might be the case in certain
circumstances, as for example, in the case of long-term facilitation
in Aplysia sensory neurons [72], it is difficult to reconcile the free
diffusion of cAMP with the high spatial organization of the cAMP
signaling cascade (adenylyl cyclases, PKAs, AKAPs, PDEs, etc.)
[11,57,59,72–78]. This paradox has been partially resolved by
recent reports of restricted cAMP diffusion. A striated pattern of
cAMP signaling has been observed in cardiomyocytes with a
genetically encoded PKA-based sensor [13]. In addition, a study
by our group has revealed that in these cells, b1-adrenergic
receptors produce generalized cAMP responses, whereas b2-
adrenergic receptors generate locally confined signals [26].
Furthermore, the existence of cAMP microdomains is supported
by a body of indirect evidence [15,59,75,79–86], and the
formation of cAMP gradients is predicted on the basis of the
spatial segregation of adenylyl cyclases on the membrane and
PDEs in the cytosol [20,22,87]. Recent calculations suggest that
such gradients may have a length of 2.5–4 mm [22]. If this is
indeed the case, signals originating near the plasma membrane
could hardly reach deep inside the cell. In this perspective, GPCR-
cAMP signaling from intracellular sites might provide a new basis
to explain the activation of distant targets and the specific effects
observed with different types of activation.
In an attempt to identify the intracellular compartment(s) where
sustained TSH receptor-cAMP signaling was occurring, we
analyzed the subcellular localization of the internalized TSH,
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approaches. In agreement with previous observations [31], our
results indicate that TSH and its receptor are internalized rapidly
in endosomes. Later on, at least part of the internalized TSH is
found together with transferrin in perinuclear vesicles that
probably represent a recycling endosomal compartment. Interest-
ingly, some of these vesicles appear to contain also Gas and
adenylyl cyclases. Although we cannot exclude the possibility that
subdetectable levels of Gas may be present together with adenylyl
cyclases in early endosomes and that TSH receptor-cAMP
signaling might be taking place also in this compartment, those
perinuclear vesicles that simultaneously contain TSH, Gas, and
adenylyl cyclases are the most likely candidates to be the
intracellular sites of TSH receptor-cAMP signaling. An interesting
aspect that emerges from our experiments and that should be
taken into consideration is the highly dynamic nature of the
intracellular structures where the internalized TSH, adenylyl
cyclases, and Gas are present. These compartments appear in fact
highly complex, sometimes having specialized subdomains that
prevalently contain one component and rapidly exchange their
contents by fusing to each other or through budding of new
vesicles. Additional studies, probably requiring the generation of
better antibodies and new tools to simultaneously monitor the
localization of the receptor, Gas and adenylyl cyclases in real time,
are needed to further investigate the microscopic anatomy and the
dynamic nature of the intracellular cAMP signaling compart-
ment(s).
In summary, our data show that GPCR signaling in a
physiological setting may be more complex than current
knowledge, based mostly on studies with transfected cells, suggests.
In particular, the subcellular localization of GPCRs, either on the
plasma membrane or intracellular, appears to be an important
parameter affecting the duration and the spatial pattern of
downstream signals. These findings may lead to reconsidering
the current model of GPCR signaling and suggest new and
intriguing scenarios on the function of GPCRs inside the cell.
Materials and Methods
Ethics Statement
All animal work was done according to the regulations and with
the permission of the government of Lower Franconia.
Materials and Reagents
Cell culture media and reagents were from Pan Biotech. Glass-
bottom Petri dishes were from World Precision Instruments.
Collagen and dispase were from Roche Diagnostics. Bovine TSH
(bTSH), dynasore, the mouse monoclonal antibody against Golgi
58K protein, the cAMP enzyme immunoassay kit (CA200), and
alumina WN-6 columns were from Sigma-Aldrich; 7-deacetyl-7-
[O-(N-methylpiperazino)-c-butyryl)]-forskolin (DMPB-forskolin)
was from Merck. Rabbit polyclonal antibodies against Gas,
adenylyl cyclase III, and adenylyl cyclase V/VI were from Santa
Cruz Biotechnology. Antibodies against Rab7 (mouse monoclo-
nal), Na
+/K
+ ATPase (mouse monoclonal), and EEA1 (rabbit
polyclonal) were from Abcam. Antibodies against VASP (rabbit
monoclonal) and P-VASP (Ser 157, rabbit polyclonal) were from
Cell Signaling Technology. Cy2-conjugated anti-rabbit and anti-
mouse polyclonal antibodies were from Jackson ImmunoResearch.
Collagenase I and II, Alexafluor488 and Alexafluor594 succini-
midyl esters, the Alexafluor594-conjugated goat anti-rabbit
polyclonal antibody, Alexafluor488-conjugated transferrin, Alexa-
fluor488-conjugated phalloidin, the rabbit anti-Alexafluor488
antibody, and Dynabeads Biotin Binder magnetic beads were
from Invitrogen. The goat anti-rabbit and anti-mouse antibodies
conjugated with horseradish peroxidase were from Amersham
Pharmacia Biotech and Millipore. The ECL detection kit was
from Amersham Pharmacia Biotech. Effectene transfection
reagent was from Qiagen. Biotinylated concanavalin A was from
Vector Laboratories. [a-
32P]ATP was from PerkinElmer Life
Sciences. All other reagents were from Sigma-Aldrich.
Generation and Characterization of Transgenic Mice
To generate transgenic cAMP-sensor mice, we followed the
strategy used for GFP mice [23]. FVB one-cell embryos were
injected by standard procedures with a genetic construct in which
the sensor sequence was inserted between the CAG promoter and
the rabbit b-globin polyadenylation signal (See Figure 1A). The
original pCAGGS expression vector has been described and
provided by J. Miyazaki [88]. The screening of pups for transgene
insertion was performed by PCR analysis as previously described
[26]. Three transgenic lines were obtained that showed different
levels of fluorescence. The line with the highest expression was
used for further experiments. Mice and freshly isolated organs
were imaged with a Leica macroFluo (Z6APO-A) microscope,
using the YFP emission filter.
Cell Culture
Mouse thyroid follicles were isolated according to a previously
published protocol [30], with minor modifications. Thyroid lobes
were dissected from 1–2 mo-old mice. The lobes were collected in
a 1.5-ml microcentrifuge tube, containing 1 ml of digestion
medium, which consisted of 100 U/ml collagenase I, 100 U/ml
collagenase II, and 1 U/ml dispase, dissolved in Dulbecco’s
modified Eagle’s medium (DMEM)/F-12. Enzymatic digestion
was carried out for 1 h in a 37uC water bath, with manual shaking
every 15 min. After digestion, isolated individual follicles were
washed three times with culture medium and plated on glass-
bottom 35-mm Petri dishes, coated with a thin layer of collagen
gel. The collagen gel was prepared by spreading 8 ml of a collagen
solution (3 mg/ml in 0.2% acetic acid) onto the glass surface,
followed by addition of a neutralizing solution (0.4 M NaHCO3,
0.2 M HEPES [pH 7.4]). For the culture of individual thyroid
cells, follicles isolated from two to three mice were seeded in a 100-
mm culture dish and grown to confluence in a monolayer for 3–
4 d. They were then completely dissociated to single cells with
trypsin (0.25%)-EDTA (0.02%) and plated on 24-mm glass
coverslips. Follicles and isolated thyroid cells were maintained in
DMEM/F-12+20% FCS (37uC, 5% CO2).
FRTL5 cells were cultured in Coon’s modified Ham’s F12
medium supplemented with 5% FCS, 1% penicillin, 1%
streptomycin, and a mixture of five hormones, and bTSH (6H)
as previously described [89]. Twenty-four hours before the cell
fractionation and adenylyl cyclase assay experiments, FRTL5 cells
were switched to complete medium without bTSH (5H).
Primary mouse embryonic fibroblasts (MEFs) and cortical
neurons were isolated from embryonic day (E) 14.5 transgenic
embryos as previously described [14,90]. Cortices were dissociated
with trypsin and cells were plated onto poly-D-lysine-coated glass
coverslips in the serum-free Neurobasal-A medium containing B-
27 supplement, 0.5 mM L-glutamine, antibiotics, and 25 mM
glutamate. Twenty-four hours later, the medium was changed to
glutamate-free. Experiments were performed 2 d after plating.
MEF isolation was performed using standard trypsin digestion of
the embryos with subsequent plating on glass coverslips in DMEM
medium containing 10% FCS, 2 mM L-glutamine, and antibiotics.
Imaging experiments were performed 24 h after the isolation.
Adult cardiac myocytes were isolated and measured 2–5 h after
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as described [14] and maintained for 24 h in DMEM medium
containing 10% FCS, 2 mM L-glutamine, and antibiotics.
Experiments were performed 24–48 h after the isolation. Cos-7
and HEK293 cells were cultured in DMEM+10% FCS.
TSH Labeling
TSH labeling was performed with Alexafluor488 or Alexa-
fluor594 succinimidyl esters, following the manufacturer’s proto-
col. Briefly, 5 mg of bTSH were dissolved in 0.5 ml of 0.1 M
NaHCO3 buffer (pH 8.3). Then, 0.5 mg of either reactive dye
dissolved in DMSO was added to the tube while vortexing, and
the reaction was incubated for 1 h at room temperature with
continuous stirring. The protein conjugates were separated from
the unreacted dyes by gel filtration on Sephadex G25 columns.
The concentration of TSH-Alexafluor488 and TSH-Alexa-
fluor594 in the collected fractions was about 1 mg/ml. The
degree of labeling was typically of one to two fluorescent moieties
per molecule of TSH. After labeling, the TSH preparations were
immediately aliquoted and stored at 220uC.
Determination of cAMP Levels
Cos-7 cells were transfected with human TSH receptor cDNA
or control empty vector by the diethylaminoethy-dextran method
followed by a dimethylsulfoxide shock. Two days after transfec-
tion, the cells were used for cAMP determinations and flow
immunocytofluorimetry to evaluate the transfection efficiency. For
cAMP determinations, culture medium was replaced with Krebs-
Ringer-HEPES buffer (KRH) for 30 min. Thereafter, the cells
were incubated for 60 min in fresh KRH supplemented with
25 mM rolipram and various concentrations of labeled or
unlabeled bTSH. At the end of the 1-h incubation, the medium
was discarded and samples were extracted with 0.1 M HCl. The
cell extracts were dried in a vacuum concentrator, resuspended in
water, and diluted appropriately for cAMP evaluation by
radioimmunoassay, utilizing standard procedures. cAMP levels
in primary thyroid cells were measured with a commercial ELISA
(CA200; Sigma-Aldrich), following the manufacturer’s protocol.
Evaluation of TSH-Alexa594 Specific Binding
HEK293 cells were plated on 24-mm round glass coverslips and
transfected with human TSH receptor cDNA or control empty
vector by Effectene, following the manufacturer’s protocol. After
48 h, the medium was replaced with a buffer containing 144 mM
NaCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2,2 0 m M
HEPES, 1% BSA (pH 7.3) and treated with 3 mg/ml TSH-
Alexa594. In addition, the specific binding of TSH-Alexa594 was
confirmed in primary mouse thyroid cells by competition with a
100-fold molar excess of unlabeled TSH (unpublished data). TSH-
Alexa594 bound to cells was visualized by TIRF microscopy.
FRET Measurements and Cell Imaging
For fluorescent microscopy, glass-bottom Petri dishes or glass
coverslips mounted in an experimental chamber were placed on a
Zeiss Axiovert 200 inverted microscope equipped with an oil-
immersion 636 objective, a polychrome IV light source (Till
Photonics), a 505 DCXR beam splitter, and a CoolSNAP-HQ
CCD-camera (Visitron Systems). FRET was monitored using
MetaFluor 5.0 software (Molecular Devices) as the ratio between
emission at 535620 nm (YFP) and emission at 480615 nm (CFP),
upon excitation at 436610 nm. The imaging data were analyzed
utilizing MetaMorph 5.0(Molecular Devices) and Prism (GraphPad
Software) software, by correcting for spillover of CFP into the 535-
nm channel and direct YFP-excitation, to give corrected YFP/CFP
ratio data. Images were acquired every 5 s, with 5-ms illumination
time, which resulted in negligible photobleaching for over 30-min
observation. To study agonist-induced changes in FRET, cells and
thyroid follicles were continuously superfused with phenol red–free
medium containing 1% BSA or the same plus agonists and/or
endocytosis inhibitors, with a custom apparatus. All experiments
were performed at 37uC. Confocal images were acquired with a
Leica SP5 confocal microscope (Leica). To visualize TSH-
Alexa594, fixed cells were excited with a 594-nm laser line, and
images were acquired with a high-sensitivity APD detector. TIRF
imageswereacquired with a LeicaAMTIRF microscope,equipped
with 488- and 561-nm laser lines and a fast high-sensitivity EM-
CCD camera (Cascade 512B). Confocal and TIRF images were
analyzed with ImageJ (U. S. National Institutes of Health, http://
rsb.info.nih.gov/ij/, 1997–2007). AVI Videos were compressed
with the Cinepak codec (Radius).
Immunofluorescence and BODIPY-Forskolin Labeling
Cells were plated on 24-mm glass coverslips, washed with PBS
and fixed with 4% paraformaldehyde for 15 min at room
temperature. Cells were then permeabilized with PBS+0.1%
Triton X-100 for 3 min at room temperature, blocked with
PBS+5% goat serum for 1 h at room temperature, incubated with
the indicated primary antibodies overnight at 4uC and incubated
with the appropriate secondary antibodies for 2 h at room
temperature. Antibodies against Gas, adenylyl cyclase III, adenylyl
cyclase V/VI, Golgi 58K, VASP, and P-VASP were used at 1:50
dilution. The Rab7 antibody was used at 1:200 dilution. All
antibody solutions were prepared in PBS+5% goat serum.
Secondary antibodies were used at 1:400 (Cy2-conjugated goat
anti-rabbit and anti-mouse polyclonal antibodies) or 1:2,000
(Alexafluor594-conjugated goat anti-rabbit polyclonal antibody)
dilutions. The specificity of the immunofluorescent stainings was
evaluated by omitting the primary antibodies and by competition
with the peptides used to raise the primary antibodies (for Gas,
adenylyl cyclase III, and adenylyl cyclase V/VI). In addition, the
specificity of Gas immunofluorescence was evaluated by compar-
ing the localization of transfected Gas-YFP and Gas immuno-
staining in HEK293 cells (unpublished data). BODIPY-forskolin
labeling was performed by incubating the cells for 10 min at room
temperature with 100 nM BODIPY-forskolin dissolved in
PBS+1% BSA. Then, the cells were washed twice with PBS and
imaged immediately.
Actin Staining
Cells were plated on 24-mm glass coverslips, washed with PBS,
and then fixed with 4% paraformaldehyde for 10 min at room
temperature. Cells were then permeabilized with PBS+0.1%
Triton X-100 for 3 min at room temperature, blocked with
PBS+1% BSA for 1 h at room temperature, and incubated with
1 U of Alexafluor488-conjugated phalloidin for 20 min at room
temperature.
Electron Microscopy
Primary mouse thyroid cells were fixed with 2% paraformal-
dehyde and 0.2% glutaraldehyde in PBS for 1 h, embedded in
12% gelatin, and infiltrated with 2.3 M sucrose. Ultrathin
cryosections were obtained with a Reichert-Jung Ultracut E with
a FC4E cryoattachment and collected on copper-formvar-carbon-
coated grids. Immunogold labeling on ultrathin cryosections was
performed as previously described [91]. Briefly, the sections were
incubated with the rabbit anti-adenylyl cyclase III antibody or the
rabbit anti-Alexafluor488 antibody, followed by incubation with
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unrelated antibody or without primary antibodies. Very low levels
of labeling were detected in all control sections (unpublished data).
All samples were examined with a Philips CM10 or a Fei TECNAI
G12 electron microscope.
Preparation of Concanavalin A Magnetic Beads
Streptavidin magnetic beads (Dynabeads Biotin Binder) were
washed using a modification of the manufacturer’s protocol. Briefly,
600 ml of magnetic beads were placed in a 1.5-ml Eppendorf test
tube and were separated from the solution by placing the vial in
contact with a magnet. The supernatant was discarded by pipetting,
and the beads were washed with 1 ml of TBS buffer (150 mM
NaCl, 50 mM Tris-HCl [pH 7.4]) supplemented with 2 mM
EDTA and 1 mg/ml BSA, and resuspended in 600 ml of the same
buffer. Then, 60 ml of biotinylated concanavalin A (5 mg/ml) were
added, and the suspension was mixed in a rotor for 60 min at room
temperature to allow binding of biotinylated concanavalin A to
streptavidin. Finally, the beads were washed thrice with TBS buffer
supplemented with 2 mM EDTA and 1 mg/ml BSA, and
resuspended in 600 ml of homogenization buffer (HB: 250 mM
sucrose, 25 mM KCl, 2.5 mM Mg(OAc)2, 25 mM Hepes/KOH
[pH 7.4]) and stored at 4uC until use.
Cell Fractionation
The protocol for plasma membrane separation with concanav-
alin A immobilized on magnetic beads was based on the method
described by Lee et al. [47]. FRTL5 cells (20 100-mm Petri dishes
per condition) were stimulated with 30 U/l bTSH for 30 min at
37uC where indicated, and harvested by trypsinization. The
subsequent steps were performed at 4uC. First, FRTL5 cells were
washed once with 5H medium and twice with TBS, and
resuspended in HB. Then, the equivalent of 100 ml of concanav-
alin A beads for each Petri dish was added to the cell suspension,
and the samples were incubated for 30 min at 37uC under
continuous rotation. At the end of the first incubation, the cells
were lysed by gently passing them eight times through a 1-ml
syringe with a 26G needle, and the plasma membrane fraction
bound to the beads was separated with the help of a magnet.
Thereafter, the nuclei were sedimented by centrifuging the
samples at 8006g for 10 min at 4uC. The remaining postnuclear
supernatant was further purified by adding 100 ml of concanavalin
A beads for each Petri dish and repeating the incubation and the
magnetic separation procedure to give rise to a second bead-
bound fraction and to the final intracellular fraction. The beads
with the attached fractions were washed twice with HB
supplemented with 1 mg/ml BSA and twice with HB. For
Western blot experiments, the proteins bound to the magnetic
beads were eluted by resuspending the beads in SDS sample buffer
(2% SDS, 10% glycerol, 50 mM dithiothreitol, 0.01% bromophe-
nol blue, 62.5 mM Tris/HCl [pH 6.8]), incubating them at 60uC
for 10 min and removing the beads with the help of a magnet. For
adenylyl cyclase activity determinations, the beads with the
attached membrane fraction were resuspended in HB buffer and
used directly in the adenylyl cyclase assay.
Adenylyl Cyclase Assay
The determination of adenylyl cyclase activity was based on the
method originally described by Jakobs et al. [92,93]. Briefly,
300 mg of proteins were added to an incubation medium in a total
volume of 100 ml with final concentrations of 50 mM Tris/HCl
(pH 7.4), 300 mM sucrose, 100 mM cAMP, 10 mM GTP, 100 mM
ATP, 1.25 mM Mg(Ac)2, 100 mM IBMX, 0.2% BSA, 15 mM
creatine phosphate, and 0.4 mg/ml creatine kinase. Samples were
incubated with about 300,000 cpm of [a-
32P]-ATP for 60 min in
the incubation medium. The reaction was stopped by addition of
400 ml of a 125 mM ZnAc solution and 500 ml of a 144 mM
Na2CO3 solution. Samples were centrifuged for 5 min at
14,000 rpm in a laboratory microcentrifuge. Finally, 800 mlo f
the resulting supernatant were applied to alumina WN-6 columns
that were eluted twice with 2 ml of 100 mM Tris/HCl (pH 7.4).
The eluates were counted in a b-counter.
Analysis of VASP Phosphorylation
Primary mouse thyroid cells were seeded in six-well plates and
starved in serum-free medium for 4 h. Thereafter, the cells were
preincubated in serum-free medium plus/minus endocytosis
inhibitors and incubated at 37uC in the presence of 1 U/l bTSH
for 30 min. This concentration of TSH was chosen because it
elicited a robust phosphorylation of VASP, without causing the
VASP signal to be completely saturated. At the end of the
incubation, the cells were washed with PBS, lysed with SDS
sample buffer, and immediately heated for 5 min at 95uC. The
levels of VASP phosphorylation were evaluated by Western blot
analysis. Afterwards, the membranes were stripped and reprobed
with an antibody against total VASP.
Western Blot Analysis
Protein concentration was determined by BCA assay. Protein
extracts were electrophoresed on a 10% SDS polyacrylamide gel
and electro-transferred to a nitrocellulose membrane. Membranes
were blocked with TBS-T+3% milk, probed with the indicated
primary antibody overnight at 4uC, and incubated with the
appropriate horseradish peroxidase-conjugated secondary anti-
body for 1 h at room temperature. The following dilutions of
primary antibodies were used: anti-Na
+/K
+ ATPase 1:10,000,
anti-EEA1 1:400, anti-Golgi 58K 1:5,000, anti-Gas 1:10,000, and
anti-adenylyl cyclase III 1:10,000. Detection was performed
utilizing the ECL detection kit.
Simulations
Simulations were performed in the Virtual Cell modeling
environment [48–50]. The receptor was placed on the plasma
membrane. G-proteins and adenylyl cyclase were both on the
plasma membrane and on the membrane of the ICSC. ATP,
cAMP, PDE4, and PKA were cytosolic. In some instances, we
simulated the internalization of the receptor and its ligand to the
ICSC. We used the initial concentrations and diffusion coefficients
utilized by Neves et al. [21], which are mostly based on
experimentally determined values. Initial concentrations, dis-
played in units of molecules/mm
2 for membrane components
and mM for cytosolic components, are provided in Table S1. For
those components not shown, the initial concentration was set at
zero. Reactions and kinetic parameters are shown in Table S2.
Spatial simulations were run using the regular grid, finite volume
solver. The geometric parameters used in the simulations are
provided in Table S3. The mean steady-state concentration of
cAMP, obtained by running the model in the absence of ligand
until all the components reached steady state, was used as the
initial concentration for subsequent simulations. A detailed
description of the mathematical model and the results of additional
simulations can be found in Text S1. The entire model,
parameters and geometries are available at http://vcell.org/.
Statistical Analysis
Values are expressed as mean6standard error of the mean
(SEM). Data normality was checked with the Kolmogorov-Smirnov
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(for two groups) or one-way ANOVA followed by Bonferroni post
hoc test (for three or more groups). For analysis of signal
normalization afterTSHwashout,signal reversibilitywascalculated
from YFP/CFP ratio values by setting the minimum value equal to
zero and the value before TSH stimulation equal to 100%. The
values obtained from different replicates were globally fitted to a
first-order exponential function. Fits were compared by using F test,
having a null hypothesis that Ymax values were the same for all
datasets. Alternatively, data from each replicate were individually fit
to a first-order exponential function, and the obtained Ymax values
were compared by one-way ANOVA.
Supporting Information
Figure S1 Comparison of cAMP levels in thyroid cells
isolated from wild-type and transgenic mice. Primary
thyroid cells isolated from either wild-type or CAG-Epac1-camps
mice were starved overnight in medium without serum and
stimulated for 60 min with different concentrations of bTSH in
the presence of 750 mM IBMX. cAMP levels were determined
with an immunoenzymatic assay. Three biological replicates per
condition were used. Error bars indicate SEM.
Found at: doi:10.1371/journal.pbio.1000172.s001 (0.03 MB TIF)
Figure S2 cAMP reversibility after stimulation with a
forskolin analog. Primary mouse thyroid follicles were treated
with 7-deacetyl-7-[O-(N-methylpiperazino)-c-butyryl)]-forskolin
(DMPB-forskolin), a forskolin analog with improved water
solubility. Reported is a representative trace from a thyroid follicle
that was initially stimulated for 3 min and later on for 10 min.
Note that DMPB-forskolin produced cAMP increases comparable
to those obtained with TSH (for comparison, see Figure 5B–5D).
In contrast to what was observed with TSH, the signals produced
by DMPB-forskolin were completely reversible upon washout.
Data are representative of ten independent experiments.
Found at: doi:10.1371/journal.pbio.1000172.s002 (0.04 MB TIF)
Figure S3 Evaluation of the biological activity of TSH-
Alexa594. (A) Cos-7 cells were transfected with TSH receptor
cDNA and stimulated 48 h later with various concentrations of
either unlabeled TSH or TSH labeled with Alexafluor594. The
graph shows the levels of intracellular cAMP, measured by a
radioimmunoassay. Eight replicates for each point were used.
Error bars indicate SEM. (B) Binding of TSH-Alexa594 to
HEK293 cells expressing the TSH receptor. HEK293 cells were
transfected with either human TSH receptor cDNA or the empty
expression vector (control). Forty-eight hours after transfection, the
cells were stimulated with 3 mg/ml TSH-Alexa594 and visualized
by TIRF microscopy. The images were acquired 10 min after
addition of the fluorescent ligand. They are representative of 18–
20 cells per condition analyzed in three independent experiments.
Found at: doi:10.1371/journal.pbio.1000172.s003 (0.54 MB TIF)
Figure S4 Fluorescent TSH internalization in whole
thyroid follicles. Primary thyroid follicles obtained from
CAG-Epac1-camps mice were stimulated with 3 mg/ml TSH-
Alexa594 for 60 min, fixed, and then visualized by confocal
microscopy. To isolate the Alexa594 signal, the background
autofluorescence was subtracted from the image by spectral
unmixing. To this end, an additional reference image was
acquired at 405-nm excitation and 425–450-nm emission. This
reference image was multiplied by a correction factor (calculated
from the relative intensities of Alexa594 and of reference images of
unlabeled thyroid follicles) and subtracted from the Alexa594
image. Shown is the corrected Alexa594 image. Images are
representative of 15 follicles visualized in three independent
experiments.
Found at: doi:10.1371/journal.pbio.1000172.s004 (0.64 MB TIF)
Figure S5 Subcellular localization of Gas and adenylyl
cyclases in primary mouse thyroid cells. Cells were fixed
with 4% paraformaldehyde and stained with primary antibodies
against Gas, adenylyl cyclase III, or adenylyl cyclase V/VI. Shown
are low-magnification images acquired with a laser-scanning
confocal microscope. Images are representative of five indepen-
dent experiments.
Found at: doi:10.1371/journal.pbio.1000172.s005 (2.65 MB TIF)
Figure S6 Specificity of immunofluorescence for Gas
and adenylyl cyclases. The specificity of Gas, adenylyl cyclase
III, and adenylyl cyclase V/VI immunofluorescent stainings was
evaluated by preincubating the primary antibodies with a 5-fold
(by weight) excess of blocking peptides, followed by the standard
immunofluorescence procedure. Images are representative of three
independent experiments.
Found at: doi:10.1371/journal.pbio.1000172.s006 (2.90 MB TIF)
Figure S7 Immunogold labeling of internalized TSH (A–
C) and adenylyl cyclase III (D and E). Primarymousethyroid
cells were stimulated with normal medium (A and D) or
medium+3 mg/ml TSH-Alexa488 (B, C, and E) for 30 min.
Representative images of the intracellular localization of TSH-
Alexa488 and adenylyl cyclase III are shown. (A–C) Immunogold
labeling with an antibody against Alexa488. No staining was
observed in cells that were not stimulated with TSH-Alexa488 (A).
By contrast, in cells that were stimulated with TSH-Alexa488 for
30 min, a positive immunogold staining was present inearly and late
endosomes (B), as well as in denser vesicles probably representing a
degradative compartment (C). (D and E) Immunogold labeling with
an antibody against adenylyl cyclase III. Adenylyl cyclase III was
found occasionally on the plasma membrane and on small
subplasmalemmal vesicles (unpublished data), in the Golgi area (D)
and on endosomal membranes (E). Stimulation with TSH-Alexa488
appeared to just slightly modify the distribution of adenylyl cyclase
III, with a tendency towards a reduction in the Golgi area and an
increase in the endosomal compartment. Images are representative
of three independent experiments. Bars indicate (A) 0.16 mm, (B)
0.48 mm, (C) 0.17 mm, (D) 0.25 mm, and (E) 0.23 mm.
Found at: doi:10.1371/journal.pbio.1000172.s007 (2.26 MB TIF)
Figure S8 Effect of pH on TSH receptor-cAMP signal-
ing. Primary mouse thyroid follicles isolated from CAG-Epac1-
camps mice were preincubated for 20 min in medium adjusted to
the indicated pH values and then visualized by time-lapse
fluorescence microscopy. The cAMP response to TSH stimulation
was monitored as described above. Traces are representative of six
to eight independent experiments per condition.
Found at: doi:10.1371/journal.pbio.1000172.s008 (0.08 MB TIF)
Figure S9 Effect of varying the adenylyl cyclase density
on the ICSC membrane.
Found at: doi:10.1371/journal.pbio.1000172.s009 (0.09 MB TIF)
Figure S10 Effect of different ICSC geometries.
Found at: doi:10.1371/journal.pbio.1000172.s010 (0.27 MB TIF)
Figure S11 Effect of GPCR recycling.
Found at: doi:10.1371/journal.pbio.1000172.s011 (0.38 MB TIF)
Figure S12 Western blot analysis of VASP phosphoryla-
tion. Primary mouse thyroid cells were preincubated with normal
medium (c), medium plus 0.43 M sucrose (s) for 10 min, or
medium plus 80 mM dynasore (d) for 20 min. Cells were then
TSH Receptor-cAMP Intracellular Signaling
PLoS Biology | www.plosbiology.org 22 August 2009 | Volume 7 | Issue 8 | e1000172stimulated with 1 U/l TSH for 30 min, in the presence or absence
of endocytosis inhibitors as indicated. Levels of P-VASP (Ser 157)
and total VASP were evaluated by Western blot analysis. The
experiment was performed three times with similar results. Shown
are the results of a representative experiment.
Found at: doi:10.1371/journal.pbio.1000172.s012 (0.10 MB TIF)
Table S1 Initial concentrations of components used in
the model.
Found at: doi:10.1371/journal.pbio.1000172.s013 (0.07 MB PDF)
Table S2 Reactions and kinetic parameters used in the
model.
Found at: doi:10.1371/journal.pbio.1000172.s014 (0.07 MB PDF)
Table S3 Geometric parameters used in the model.
Found at: doi:10.1371/journal.pbio.1000172.s015 (0.71 MB PDF)
Text S1 Detailed description of the mathematical
model.
Found at: doi:10.1371/journal.pbio.1000172.s016 (0.13 MB PDF)
Video S1 3-D reconstruction of a primary mouse
thyroid follicle isolated form CAG-Epac1-camps mice.
A stack of YFP images on the z-axis was acquired with a laser-
scanning confocal microscope. The 3-D reconstruction was
performed with ImageJ software. The video shows a 360u rotation
on the y-axis.
Found at: doi:10.1371/journal.pbio.1000172.s017 (1.07 MB AVI)
Video S2 Sequence of YFP/CFP ratio images of a
thyroid follicle stimulated with 100 U/l TSH and
10 mM forskolin. The video shows the entire sequence from
which the frames reported in Figure 4A were derived. Time
between frames was 5 s. Playback is accelerated (ten frames/
second).
Found at: doi:10.1371/journal.pbio.1000172.s018 (3.71 MB AVI)
Video S3 Dynamic visualization of internalized TSH-
Alexa594. Primary mouse thyroid cells were stimulated with
3 mg/ml TSH-Alexa594 for 20 min. After a rapid wash with fresh
medium, TSH-Alexa594 fluorescence was visualized with a TIRF
microscope set to have a high penetration depth. The video shows
the entire sequence from which the frames reported in Figure 9
were derived. Time between frames was 1 s. Playback is
accelerated (ten frames/second).
Found at: doi:10.1371/journal.pbio.1000172.s019 (5.81 MB AVI)
Video S4 A 360u rotation on the x-axis of the 3-D
reconstruction in Figure 11A.
Found at: doi:10.1371/journal.pbio.1000172.s020 (0.35 MB AVI)
Video S5 A 360u rotation on the x-axis of the 3-D
reconstruction in Figure 11C.
Found at: doi:10.1371/journal.pbio.1000172.s021 (0.26 MB AVI)
Video S6 Dynamic visualization of internalized TSH-
Alexa594 and adenylyl cyclases. Primary mouse thyroid cells
were stimulated with 3 mg/ml TSH-Alexa594 for 20 min,
followed by staining with BODIPY-forskolin. TSH-Alexa594
fluorescence was visualized with a TIRF microscope set to have
a high penetration depth. Data are representative of 20 cells
analyzed in three independent experiments. Time between frames
was 10 s. Playback is accelerated (four frames/second).
Found at: doi:10.1371/journal.pbio.1000172.s022 (0.16 MB AVI)
Video S7 Effect of hypertonic sucrose on TSH-Alexa594
internalization. Primary mouse thyroid cells were preincubated
with 0.43 M sucrose for 10 min and stimulated with 3 mg/ml
TSH-Alexa 594 for 20 min in the presence of 0.43 M sucrose.
After a rapid wash with fresh medium, TSH-Alexa594 fluores-
cence was visualized with a TIRF microscope set to have a high
penetration depth. Data are representative of 18 cells analyzed in
three independent experiments. Time between frames was 10 s.
Playback is accelerated (one frame/second).
Found at: doi:10.1371/journal.pbio.1000172.s023 (0.85 MB AVI)
Video S8 Control for Videos S7 and S9. Primary mouse
thyroid cells were stimulated with 3 mg/ml TSH-Alexa594 in the
absence of endocytosis inhibitors. After a rapid wash with fresh
medium, TSH-Alexa594 fluorescence was visualized with a TIRF
microscope set to have a high penetration depth. Data are
representative of 21 cells analyzed in three independent experi-
ments. Time between frames was 10 s. Playback is accelerated
(one frame/second).
Found at: doi:10.1371/journal.pbio.1000172.s024 (1.38 MB AVI)
Video S9 Effect of dynasore on TSH-Alexa594 internal-
ization. Primary mouse thyroid cells were preincubated with
80 mM dynasore for 20 min and stimulated with 3 mg/ml TSH-
Alexa594 for 20 min, in the presence of 80 mM dynasore. After a
rapid wash with fresh medium, TSH-Alexa594 fluorescence was
visualized with a TIRF microscope set to have a high penetration
depth. Data are representative of 25 cells analyzed in three
independent experiments. Time between frames was 10 s.
Playback is accelerated (one frame/second).
Found at: doi:10.1371/journal.pbio.1000172.s025 (0.51 MB AVI)
Acknowledgments
We would like to thank Eva Schmitteckert for mouse embryo injections,
Marco Bonomi and Annette Hannawacker for cAMP assays, Stepan
Gambaryan for help with the analysis of VASP phosphorylation, Gregory
Harms for advice on confocal microscopy, Christiane Kleuss for the canine
adenylyl cyclase VI plasmid, and Moritz Bu ¨nemann, Kristina Lorenz,
Christoph Klenk, Laurinda Jaffe, Pier Paolo Di Fiore, Sara Sigismund,
Jacopo Meldolesi, and Gabriella Racchetti for helpful discussion.
Author Contributions
The author(s) have made the following declarations about their
contributions: Conceived and designed the experiments: DC. Analyzed
the data: DC CT LP. Contributed reagents/materials/analysis tools: VON
LP. Wrote the paper: DC MJL. Isolated thyroid follicles; performed FRET,
TIRF, immunofluorescence and cell fractionation experiments; generated
the mathematical model: DC. Generated and analyzed the CAG-Epac1-
camps mice; performed the FRET experiments on MEFs, cortical neurons,
macrophages, and cardiac myocytes; performed the Western blot analysis
of VASP phosphorylation: VON. Performed the electron microscopy
experiments: MCG. Performed cell fractionation and Western blot
experiments: TdF. Produced the fluorescently labeled TSH: CD.
Supervised the electron microscopy experiments: CT. Supervised the
project: MJL.
References
1. Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors.
Nat Rev Mol Cell Biol 3: 639–650.
2. Pippig S, Andexinger S, Lohse MJ (1995) Sequestration and recycling of beta 2-
adrenergic receptors permitreceptorresensitization. Mol Pharmacol 47:666–676.
3. Sorkin A, von Zastrow M (2002) Signal transduction and endocytosis: close
encounters of many kinds. Nat Rev Mol Cell Biol 3: 600–614.
4. Miaczynska M, Pelkmans L, Zerial M (2004) Not just a sink: endosomes in
control of signal transduction. Curr Opin Cell Biol 16: 400–406.
5. Polo S, Di Fiore PP (2006) Endocytosis conducts the cell signaling orchestra. Cell
124: 897–900.
6. von Zastrow M, Sorkin A (2007) Signaling on the endocytic pathway. Curr Opin
Cell Biol 19: 436–445.
TSH Receptor-cAMP Intracellular Signaling
PLoS Biology | www.plosbiology.org 23 August 2009 | Volume 7 | Issue 8 | e10001727. Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor
kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem
273: 18677–18680.
8. Slessareva JE, Routt SM, Temple B, Bankaitis VA, Dohlman HG (2006)
Activation of the phosphatidylinositol 3-kinase Vps34 by a G protein alpha
subunit at the endosome. Cell 126: 191–203.
9. Janetopoulos C, Jin T, Devreotes P (2001) Receptor-mediated activation of
heterotrimeric G-proteins in living cells. Science 291: 2408–2411.
10. Vilardaga JP, Bunemann M, Krasel C, Castro M, Lohse MJ (2003)
Measurement of the millisecond activation switch of G protein-coupled
receptors in living cells. Nat Biotechnol 21: 807–812.
11. Lohse MJ, Nikolaev VO, Hein P, Hoffmann C, Vilardaga JP, et al. (2008)
Optical techniques to analyze real-time activation and signaling of G-protein-
coupled receptors. Trends Pharmacol Sci 29: 159–165.
12. Zaccolo M, De Giorgi F, Cho CY, Feng L, Knapp T, et al. (2000) A genetically
encoded, fluorescent indicator for cyclic AMP in living cells. Nat Cell Biol 2:
25–29.
13. Zaccolo M, Pozzan T (2002) Discrete microdomains with high concentration of
cAMP in stimulated rat neonatal cardiac myocytes. Science 295: 1711–1715.
14. Nikolaev VO, Bunemann M, Hein L, Hannawacker A, Lohse MJ (2004) Novel
single chain cAMP sensors for receptor-induced signal propagation. J Biol Chem
279: 37215–37218.
15. DiPilato LM, Cheng X, Zhang J (2004) Fluorescent indicators of cAMP and
Epac activation reveal differential dynamics of cAMP signaling within discrete
subcellular compartments. Proc Natl Acad Sci U S A 101: 16513–16518.
16. Ponsioen B, Zhao J, Riedl J, Zwartkruis F, van der KG, et al. (2004) Detecting
cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac
as a novel cAMP indicator. EMBO Rep 5: 1176–1180.
17. Sato M, Hida N, Ozawa T, Umezawa Y (2000) Fluorescent indicators for cyclic
GMP based on cyclic GMP-dependent protein kinase Ialpha and green
fluorescent proteins. Anal Chem 72: 5918–5924.
18. Honda A, Adams SR, Sawyer CL, Lev-Ram V, Tsien RY, et al. (2001)
Spatiotemporal dynamics of guanosine 39,59-cyclic monophosphate revealed by
a genetically encoded, fluorescent indicator. Proc Natl Acad Sci U S A 98:
2437–2442.
19. Nikolaev VO, Gambaryan S, Lohse MJ (2006) Fluorescent sensors for rapid
monitoring of intracellular cGMP. Nat Methods 3: 23–25.
20. Kholodenko BN (2006) Cell-signalling dynamics in time and space. Nat Rev Mol
Cell Biol 7: 165–176.
21. Neves SR, Tsokas P, Sarkar A, Grace EA, Rangamani P, et al. (2008) Cell shape
and negative links in regulatory motifs together control spatial information flow
in signaling networks. Cell 133: 666–680.
22. Kholodenko BN, Kolch W (2008) Giving space to cell signaling. Cell 133:
566–567.
23. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y (1997) ‘Green
mice’ as a source of ubiquitous green cells. FEBS Lett 407: 313–319.
24. Mongillo M, McSorley T, Evellin S, Sood A, Lissandron V, et al. (2004)
Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live
neonatal rat cardiac myocytes reveals distinct functions of compartmentalized
phosphodiesterases. Circ Res 95: 67–75.
25. Terrin A, Di Benedetto G, Pertegato V, Cheung YF, Baillie G, et al. (2006)
PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with
different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol
175: 441–451.
26. Nikolaev VO, Bunemann M, Schmitteckert E, Lohse MJ, Engelhardt S (2006)
Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1-
adrenergic but locally confined beta2-adrenergic receptor-mediated signaling.
Circ Res 99: 1084–1091.
27. Vassart G, Dumont JE (1992) The thyrotropin receptor and the regulation of
thyrocyte function and growth. Endocr Rev 13: 596–611.
28. Calebiro D, de Filippis T, Lucchi S, Martinez F, Porazzi P, et al. (2006) Selective
modulation of protein kinase A I and II reveals distinct roles in thyroid cell gene
expression and growth. Mol Endocrinol 20: 3196–3211.
29. Toda S, Koike N, Sugihara H (2001) Thyrocyte integration, and thyroid
folliculogenesis and tissue regeneration: perspective for thyroid tissue engineer-
ing. Pathol Int 51: 403–417.
30. Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, et al. (2006)
Thyroid-specific enhancer-binding protein/NKX2.1 is required for the
maintenance of ordered architecture and function of the differentiated thyroid.
Mol Endocrinol 20: 1796–1809.
31. Baratti-Elbaz C, Ghinea N, Lahuna O, Loosfelt H, Pichon C, et al. (1999)
Internalization and recycling pathways of the thyrotropin receptor. Mol
Endocrinol 13: 1751–1765.
32. Lahuna O, Quellari M, Achard C, Nola S, Meduri G, et al. (2005) Thyrotropin
receptor trafficking relies on the hScrib-betaPIX-GIT1-ARF6 pathway. EMBO J
24: 1364–1374.
33. Frenzel R, Voigt C, Paschke R (2006) The human thyrotropin receptor is
predominantly internalized by beta-arrestin 2. Endocrinology 147: 3114–3122.
34. Tokunaga M, Imamoto N, Sakata-Sogawa K (2008) Highly inclined thin
illumination enables clear single-molecule imaging in cells. Nat Methods 5:
159–161.
35. Helms JB (1995) Role of heterotrimeric GTP binding proteins in vesicular
protein transport: indications for both classical and alternative G protein cycles.
FEBS Lett 369: 84–88.
36. Sato M, Blumer JB, Simon V, Lanier SM (2006) Accessory proteins for G
proteins: partners in signaling. Annu Rev Pharmacol Toxicol 46: 151–187.
37. Mons N, Harry A, Dubourg P, Premont RT, Iyengar R, et al. (1995)
Immunohistochemical localization of adenylyl cyclase in rat brain indicates a
highly selective concentration at synapses. Proc Natl Acad Sci U S A 92:
8473–8477.
38. Head BP, Patel HH, Roth DM, Lai NC, Niesman IR, et al. (2005) G-protein-
coupled receptor signaling components localize in both sarcolemmal and
intracellular caveolin-3-associated microdomains in adult cardiac myocytes.
J Biol Chem 280: 31036–31044.
39. Vanvooren V, Allgeier A, Cosson E, Van Sande J, Defer N, et al. (2000)
Expression of multiple adenylyl cyclase isoforms in human and dog thyroid. Mol
Cell Endocrinol 170: 185–196.
40. Ghosh RN, Gelman DL, Maxfield FR (1994) Quantification of low density
lipoprotein and transferrin endocytic sorting in HEp2 cells using confocal
microscopy. J Cell Sci 107 (Pt 8): 2177–2189.
41. Gao YS, Alvarez C, Nelson DS, Sztul E (1998) Molecular cloning,
characterization, and dynamics of rat formiminotransferase cyclodeaminase, a
Golgi-associated 58-kDa protein. J Biol Chem 273: 33825–33834.
42. Liu CY, Zhang H, Christofi FL (1998) Adenylyl cyclase co-distribution with the
CaBPs, calbindin-D28 and calretinin, varies with cell type: assessment with the
fluorescent dye, BODIPY forskolin, in enteric ganglia. Cell Tissue Res 293:
57–73.
43. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, et al. (2006) Dynasore, a
cell-permeable inhibitor of dynamin. Dev Cell 10: 839–850.
44. Faundez V, Hartzell HC (2004) Intracellular chloride channels: determinants of
function in the endosomal pathway. Sci STKE 2004: re8.
45. Moore WV, Wolff J (1974) Thyroid-stimulating hormone binding to beef thyroid
membranes. Relation to adenylate cyclase activity. J Biol Chem 249: 6255–6263.
46. Ambesi-Impiombato FS, Picone R, Tramontano D (1982) Influence of
hormones and serum on growth and differentiation of the thyroid cell strain
FRTL. In: Sato OH, Pardee A, Sirbasku DA, eds (1982) Growth of cells in
hormonally defined media. New York: Cold Spring Harbor Laboratory Press.
pp 483–492.
47. Lee YC, Block G, Chen H, Folch-Puy E, Foronjy R, et al. (2008) One-step
isolation of plasma membrane proteins using magnetic beads with immobilized
concanavalin A. Protein Expr Purif 62: 223–229.
48. Loew LM, Schaff JC (2001) The Virtual Cell: a software environment for
computational cell biology. Trends Biotechnol 19: 401–406.
49. Slepchenko BM, Schaff JC, Carson JH, Loew LM (2002) Computational cell
biology: spatiotemporal simulation of cellular events. Annu Rev Biophys Biomol
Struct 31: 423–441.
50. Slepchenko BM, Schaff JC, Macara I, Loew LM (2003) Quantitative cell biology
with the Virtual Cell. Trends Cell Biol 13: 570–576.
51. Roger PP, Rickaert F, Lamy F, Authelet M, Dumont JE (1989) Actin stress fiber
disruption and tropomyosin isoform switching in normal thyroid epithelial cells
stimulated by thyrotropin and phorbol esters. Exp Cell Res 182: 1–13.
52. Deery WJ, Heath JP (1993) Phagocytosis induced by thyrotropin in cultured
thyroid cells is associated with myosin light chain dephosphorylation and stress
fiber disruption. J Cell Biol 122: 21–37.
53. Fortemaison N, Blancquaert S, Dumont JE, Maenhaut C, Aktories K, et al.
(2005) Differential involvement of the actin cytoskeleton in differentiation and
mitogenesis of thyroid cells: inactivation of Rho proteins contributes to cyclic
adenosine monophosphate-dependent gene expression but prevents mitogenesis.
Endocrinology 146: 5485–5495.
54. Lebrand C, Dent EW, Strasser GA, Lanier LM, Krause M, et al. (2004) Critical
role of Ena/VASP proteins for filopodia formation in neurons and in function
downstream of netrin-1. Neuron 42: 37–49.
55. Trichet L, Sykes C, Plastino J (2008) Relaxing the actin cytoskeleton for
adhesion and movement with Ena/VASP. J Cell Biol 181: 19–25.
56. von Zastrow M (2001) Role of endocytosis in signalling and regulation of G-
protein-coupled receptors. Biochem Soc Trans 29: 500–504.
57. Nikolaev VO, Lohse MJ (2006) Monitoring of cAMP synthesis and degradation
in living cells. Physiology (Bethesda ) 21: 86–92.
58. Adams SR, Harootunian AT, Buechler YJ, Taylor SS, Tsien RY (1991)
Fluorescence ratio imaging of cyclic AMP in single cells. Nature 349: 694–697.
59. Zaccolo M (2006) Phosphodiesterases and compartmentalized cAMP signalling
in the heart. Eur J Cell Biol 85: 693–697.
60. Dunn TA, Wang CT, Colicos MA, Zaccolo M, DiPilato LM, et al. (2006)
Imaging of cAMP levels and protein kinase A activity reveals that retinal waves
drive oscillations in second-messenger cascades. J Neurosci 26: 12807–12815.
61. Warrier S, Belevych AE, Ruse M, Eckert RL, Zaccolo M, et al. (2005) Beta-
adrenergic- and muscarinic receptor-induced changes in cAMP activity in adult
cardiac myocytes detected with FRET-based biosensor. Am J Physiol Cell
Physiol 289: C455–C461.
62. Lissandron V, Rossetto MG, Erbguth K, Fiala A, Daga A, et al. (2007)
Transgenic fruit-flies expressing a FRET-based sensor for in vivo imaging of
cAMP dynamics. Cell Signal 19: 2296–2303.
63. Kim JW, Roberts CD, Berg SA, Caicedo A, Roper SD, et al. (2008) Imaging
cyclic AMP changes in pancreatic islets of transgenic reporter mice. PLoS ONE
3: e2127. doi:10.1371/journal.pone.0002127.
64. Feliciello A, Giuliano P, Porcellini A, Garbi C, Obici S, et al. (1996) The v-Ki-
Ras oncogene alters cAMP nuclear signaling by regulating the location and the
TSH Receptor-cAMP Intracellular Signaling
PLoS Biology | www.plosbiology.org 24 August 2009 | Volume 7 | Issue 8 | e1000172expression of cAMP-dependent protein kinase IIbeta. J Biol Chem 271:
25350–25359.
65. Feliciello A, Gallo A, Mele E, Porcellini A, Troncone G, et al. (2000) The
localization and activity of cAMP-dependent protein kinase affect cell cycle
progression in thyroid cells. J Biol Chem 275: 303–311.
66. Porcellini A, Messina S, De Gregorio G, Feliciello A, Carlucci A, et al. (2003)
The expression of the thyroid-stimulating hormone (TSH) receptor and the
cAMP-dependent protein kinase RII beta regulatory subunit confers TSH-
cAMP-dependent growth to mouse fibroblasts. J Biol Chem 278: 40621–40630.
67. Goichot B, Brandenberger G, Saini J, Wittersheim G, Follenius M (1994)
Nycthemeral patterns of thyroid hormones and their relationships with
thyrotropin variations and sleep structure. J Endocrinol Invest 17: 181–187.
68. Smith SJ, Augustine GJ (1988) Calcium ions, active zones and synaptic
transmitter release. Trends Neurosci 11: 458–464.
69. Thorn P, Lawrie AM, Smith PM, Gallacher DV, Petersen OH (1993) Local and
global cytosolic Ca2+ oscillations in exocrine cells evoked by agonists and
inositol trisphosphate. Cell 74: 661–668.
70. Bacskai BJ, Hochner B, Mahaut-Smith M, Adams SR, Kaang BK, et al. (1993)
Spatially resolved dynamics of cAMP and protein kinase A subunits in Aplysia
sensory neurons. Science 260: 222–226.
71. Chen C, Nakamura T, Koutalos Y (1999) Cyclic AMP diffusion coefficient in
frog olfactory cilia. Biophys J 76: 2861–2867.
72. Emptage NJ, Carew TJ (1993) Long-term synaptic facilitation in the absence of
short-term facilitation in Aplysia neurons. Science 262: 253–256.
73. Wong W, Scott JD (2004) AKAP signalling complexes: focal points in space and
time. Nat Rev Mol Cell Biol 5: 959–970.
74. Cooper DM (2005) Compartmentalization of adenylate cyclase and cAMP
signalling. Biochem Soc Trans 33: 1319–1322.
75. Zaccolo M, Di Benedetto G, Lissandron V, Mancuso L, Terrin A, et al. (2006)
Restricted diffusion of a freely diffusible second messenger: mechanisms
underlying compartmentalized cAMP signalling. Biochem Soc Trans 34:
495–497.
76. Dodge-Kafka KL, Langeberg L, Scott JD (2006) Compartmentation of cyclic
nucleotide signaling in the heart: the role of A-kinase anchoring proteins. Circ
Res 98: 993–1001.
77. Vandecasteele G, Rochais F, Abi-Gerges A, Fischmeister R (2006) Functional
localization of cAMP signalling in cardiac myocytes. Biochem Soc Trans 34:
484–488.
78. Lohse MJ, Bunemann M, Hoffmann C, Vilardaga JP, Nikolaev VO (2007)
Monitoring receptor signaling by intramolecular FRET. Curr Opin Pharmacol
7: 547–553.
79. Jurevicius J, Fischmeister R (1996) cAMP compartmentation is responsible for a
local activation of cardiac Ca2+ channels by beta-adrenergic agonists. Proc Natl
Acad Sci U S A 93: 295–299.
80. Rich TC, Fagan KA, Nakata H, Schaack J, Cooper DM et al. (2000) Cyclic
nucleotide-gated channels colocalize with adenylyl cyclase in regions of restricted
cAMP diffusion. J Gen Physiol 116: 147–161.
81. Rich TC, Fagan KA, Tse TE, Schaack J, Cooper DM, et al. (2001) A uniform
extracellular stimulus triggers distinct cAMP signals in different compartments of
a simple cell. Proc Natl Acad Sci U S A 98: 13049–13054.
82. Barnes AP, Livera G, Huang P, Sun C, O’Neal WK, et al. (2005)
Phosphodiesterase 4D forms a cAMP diffusion barrier at the apical membrane
of the airway epithelium. J Biol Chem 280: 7997–8003.
83. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, et
al. (2005) The protein kinase A anchoring protein mAKAP coordinates two
integrated cAMP effector pathways. Nature 437: 574–578.
84. Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, et al. (2005)
Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes
heart failure and arrhythmias. Cell 123: 25–35.
85. Zhang J, Hupfeld CJ, Taylor SS, Olefsky JM, Tsien RY (2005) Insulin disrupts
beta-adrenergic signalling to protein kinase A in adipocytes. Nature 437:
569–573.
86. Mongillo M, Tocchetti CG, Terrin A, Lissandron V, Cheung YF, et al. (2006)
Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac
inotropy via an NO/cGMP-dependent pathway. Circ Res 98: 226–234.
87. Fell DA (1980) Theoretical analyses of the functioning of the high- and low-Km
cyclic nucleotide phosphodiesterases in the regulation of the concentration of
adenosine 39,59-cyclic monophosphate in animal cells. J Theor Biol 84: 361–385.
88. Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression
transfectants with a novel eukaryotic vector. Gene 108: 193–199.
89. Persani L, Tonacchera M, Beck-Peccoz P, Vitti P, Mammoli C, et al. (1993)
Measurement of cAMP accumulation in Chinese hamster ovary cells transfected
with the recombinant human TSH receptor (CHO-R): a new bioassay for
human thyrotropin. J Endocrinol Invest 16: 511–519.
90. Bryja V, Bonilla S, Arenas E (2006) Derivation of mouse embryonic stem cells.
Nat Protoc 1: 2082–2087.
91. Schiaffino MV, Tacchetti C (2005) The ocular albinism type 1 (OA1) protein
and the evidence for an intracellular signal transduction system involved in
melanosome biogenesis. Pigment Cell Res 18: 227–233.
92. Jakobs KH, Saur W, Schultz G (1976) Reduction of adenylate cyclase activity in
lysates of human platelets by the alpha-adrenergic component of epinephrine.
J Cyclic Nucleotide Res 2: 381–392.
93. Klotz KN, Cristalli G, Grifantini M, Vittori S, Lohse MJ (1985) Photoaffinity
labeling of A1-adenosine receptors. J Biol Chem 260: 14659–14664.
TSH Receptor-cAMP Intracellular Signaling
PLoS Biology | www.plosbiology.org 25 August 2009 | Volume 7 | Issue 8 | e1000172